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Citrus canker, caused by Xanthomonas axonopodis pv. citri (Xac), is one of the 
most devastating citrus diseases that affects citrus production worldwide. The current 
recommended means to control canker are windbreaks, copper sprays, and control of 
leafminer, its insect vector, with copper sprays being most effective. However, there is  
growing concern about the buildup of copper in groves leading to phytotoxicity, decreased 
plant productivity, copper resistance development, and copper contamination of ground 
and river water. The goal of this study was to develop a non-copper based treatment for 
citrus canker. Using virulent bacterial viruses (phages) that specifically targeted to Xac is 
an approach that is not harmful to humans, animals, plants, associated beneficial 
microflora, or the environment. I report here the isolation and characterization of three 
virulent phages for Xac that differ in host range and morphology. Genomic analysis 
showed that CCP504 is a phiKMV-like phage, CCP513 is a novel siphophage, and 
CCP509 is a T4-like phage type, respectively. All three phages appear to utilize type IV 
pili as their primary receptors for adsorption.  Greenhouse studies were conducted to 
evaluate the efficacy of phage therapy to control canker formation on Hamlin sweet 
oranges using a phage cocktail composed of three KMV-like podophages (CCP504, 
CCP505 and CCP511) and one siphophage (CCP513). Both pre- and post-treatments with 
this phage cocktail at an MOI of 20 resulted in a significant reduction in lesion formation 
on leaves of the treated plants as compared to non-treated plants. My research 
demonstrates that bacteriophages can serve as an alternative control strategy for Xac that is 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW  
 
The pathogen 
Xanthomonas axonopodis pv. citri (Xac) is a rod-shaped Gram-negative bacterium 
with a single polar flagellum (Agrios, 1997). It is the causal agent of citrus canker, a 
disease that affects citrus production worldwide (Gottwald et al., 2002). The pathogen 
causes distinct raised necrotic lesions on leaves, stems, and fruits. Severe infections can 
lead to defoliation, blemished fruit, premature fruit drop, twig dieback, and general tree 
decline (Schubert et al., 2001). It can cause serious damage to all citrus cultivars and some 
citrus relatives, but is not harmful to humans or animals (Dewdney et al.). The Asiatic type 
of canker (Canker A), caused by Xac, is the most widespread and causes the most severe 
form of the disease, whereas the cancrosis B and C caused by X. axonopodis pv. 
aurantifolii (Graham et al., 2004) are less severe. The canker A-strain is most severe on 
grapefruit, some sweet oranges Hamlin, Pineapple and Naval, Mexican (Key) lime, and the 
hybrids of trifoliate orange used for rootstocks. The cancrosis B-strain is most serious on 
lemons and also infects Mexican lime, sour orange and pummelo. The C-strain is only 
present in Brazil and infects Mexican (Key) lime (Graham et al., 2004; Schubert et al., 
2001). In nature, the canker A-strain gradually supplants and dominates over the B-strain, 
when both are present.  More recently, primers based on sequence differences in 16S-23S 
internally transcribed spacers (ITS) and the plasmid gene pthA were developed to 




Xac produces abundant extracellular polysaccharide (EPS) and xanthan that 
encapsulates bacterial cells in the late logarithmic and stationary growth phases, which 
contribute to inoculum survival (Goto and Hyodo, 1985). Pathogenicity factors such as 
type III secretion systems (T3SS) and the effector gene for pathogenicity (pthA) are critical 
for the development of citrus canker symptoms (Das, 2003). PthA is translocated into host 
cells via T3SS and its expression is sufficient for symptoms (hypertrophy, hyperplasia and 
cell death) that are diagnostic of citrus canker disease (Duan et al., 1999). In Xac, 
production of virulence factors is controlled by a cluster of regulation of pathogenicity 
factors (rpf) that encoded elements of a cell-cell communication system called quorum 
sensing (QS) (Barber et al., 1997). The QS regulatory system of Xac is mediated by a 
diffusible signal factor (DSF) (Ryan et al., 2011; 2015). The DSF-mediated QS in Xac 
influences the synthesis of  extracellular enzymes such as endoglucanase, protease, and 
endomannanase, and the xanthan EPS, as well as alterations in biofilm formation that 
assists in egression of the pathogen from the canker lesion (Brunings and Gabriel, 2003; Li 
et al., 2019). Once within the apoplastic space, the bacteria adheres to the host cell wall 
surfaces via the hypersensitive reaction and pathogenicity (hrp) pili (He, 1998) or type IV 
pili (T4P) (Brunings and Gabriel, 2003). Xac can also manipulate host responses via a 
plant natriuretic peptide (PNP)-like protein (XacPNP). The XacPNP acts to improve host 
photosynthesis, which results in more new tissue growth during infection. This regulation 
of host development suits the biotrophic lifestyle of Xac and prolongs its survival (Gottig 
et al., 2010).  
 Xac is not a systemic pathogen, however all tissues above ground are susceptible to 




Schubert et al., 2001). The optimum temperature for infection is between 20 and 30ºC 
(Koizumi and Kochinotsu, 1977). Under less than ideal infection and incubation 
conditions, symptoms may take up to two months or more to be noticeable (Schubert et al., 
2001). An inoculum source for young exposed tissue on the same plant or new plants is 
bacterial ooze from lesions containing high concentrations of biofilm-coated aggregates of 
Xac (Timmer et al., 1991).  Xac survives primarily and seasonally within the margins of 
the lesions. Outside of the lesions, Xac only survives 1-3 days on inanimate surfaces, such 
as agricultural equipment and clothing, and no more than two months in soil due to 
antagonism and competition with saprophytes (Graham et al., 1989; Schubert et al., 2001). 
Xac infections occur primarily through stomates and wounds produced via wind-driven 
rain and by insects (Das, 2003). Another factor that can exacerbate the incidence and 
severity of citrus canker is larval feeding by Asian citrus leaf miner (CLM; Phyllocnistis 












Citrus canker continues to be  a potential threat to worldwide citriculture (Das, 
2003). The disease is thought to have originated in southeastern Asia or India and spread 
through much of Asia, to Japan, southern and central Africa, the Middle East, Australia, 
New Zealand, the Pacific Islands, South America and the southeastern United States of 
America  (Schubert and Miller, 1996). In the United States, Florida has greater than 150-
year history of citrus production and produces three quarters of total US citrus (Zhou et al., 
2011). Canker has become endemic in Florida since the end of a state/federal eradication 




From 1996 through late 1999, the up-front costs of the eradication program 
increased from approximately $10 million to $50 million/year. In 2000-2001, an all–out 
eradication program was put in place against further spread of the disease, which increased 
the expense up to $200 million dollars (Schubert et al., 2001). Table 1 shows the statistical 
data of the citrus canker eradication program in the areas affected by this disease in Florida 
as of January 2001.  
 
 
Table 1. Citrus Canker Eradication Program statistics in the geographic areas where citrus 














1 1,000 568,807 290,718 
Southwest FL 
(Hendry, Collier) 
6 159 2,299 532,281 
West central FL 
(Manatee, 
Hillsborough) 
3 162 5,144 100,811 




In addition to threatening the growth and survival of citrus, the disease makes fruits 
unappealing and unmarketable. Twig dieback, fruit blemish, and early fruit drop, which 
occur during the advances stages of the disease, have major economic impacts (Schubert et 
al., 2001). Even with current control  measures in place, estimates from studies in South 
America show fresh fruit crop losses at $80 to $160/acre/year for early oranges, $31 to 
$79/acre/year for mid-season oranges, and $69 to $137/acre/year for grapefruit (Schubert 
et al., 2001).Furthermore, there has been a decline of 32.7% in value of sale from a high of 




recent economic impact analysis showed that grapefruit, Florida’s most important fresh 
fruit species, is declining in value. In 2005-2006, grapefruit was valued at $174 million, 
but by the 2009-2010 crop year, it had experienced a 30% decrease in value; it was worth 
only $123 million (Graham et al., 2010). This loss is due to legal restrictions preventing 
the packing of fruit exposed to canker, restriction of shipping to export markets, 
abandonment of groves due to loss of profitability, diversion of fruit to the production of 
juice and a decreased in consumption (Ritenour et al., 2010).   
Current control measures  
In countries where citrus canker has not yet occurred, control measures rely heavily 
on quarantine to prevent the introduction and establishment of Xac. In regions where 
canker has occurred but not yet become endemic, measures of control are focused on 
isolation and eradication of the pathogen, minimization of dissemination, reduction of  
inoculum sources, and protection of susceptible tissue from infection (Behlau et al., 2016). 
In regions where citrus canker has become endemic and an eradication program is no 
longer feasible, measures for disease management include: the planting of citrus canker-
free nursery stock, the use of less susceptible citrus cultivars, the deployment of  arboreal 
windbreaks, the treatment of plants with copper-based bactericides, the control of citrus 
leaf miner and the application of systemic acquired resistance (SAR) inducers (Behlau et 
al., 2008; Graham et al., 2010; Leite Jr and Mohan, 1990; Stein et al., 2007). Among  these 
integrated measurements, the most common and highly effective practices are windbreak 
and copper spray (Gottwald and Timmer, 1995; Moschini et al., 2014). The effectiveness 
of copper bactericides for citrus disease control has been comprehensively evaluated over 




endemic areas is highly dependent on copper sprays (Behlau et al., 2017).  However, long-
term use of copper bactericides has several disadvantages including accumulation in soil 
which has negative impacts on root growth and nutrient uptake by citrus trees, fruit 
blemishing as a result of phytotoxicity and development of copper-resistance due to the 
ability of Xac to a acquire plasmid-borne gene(s) conferring resistance in xanthomonad 
populations (Graham et al., 2010). Kandeler et al (1996) observed that microbial biomass, 
enzyme activity, and functional diversity of soil microbial communities decreased with 
increasing Cu pollution (Kandeler et al., 1996; Zhou et al., 2011). Furthermore, when using 
copper bactericides exclusively, citrus canker management on susceptible cultivars is 
challenging because wind-blown rain introduces Xac directly into stomata, bypassing the 
protective copper film on the plant surface (Ference et al., 2018). Thus, there is an urgent 
need to develop new environmentally-friendly control strategies to combat citrus canker. 
Bacteriophage biology 
Bacteriophages (phages) are viruses that infect bacteria, and are the most numerous 
and most diverse life forms on earth, estimated at 1031 tailed phages in the biosphere 
(Brüssow and Hendrix, 2002; Clokie et al., 2011). There are many different types of 
phages that range from double stranded DNA (dsDNA) to single stranded RNA phages. 
The dsDNA tailed phages have been classified into three families: Podoviridae, 
Siphoviridade and Myoviridae that belong to the order of Caudoviridales (‘cauda’, which 
is Latin for tail) which account for ~95% of all reported phages (Ackermann, 2006). 
Podophages have short, non-contractile tails, siphophages have long, non-contractile tails, 
and myophages have long contractile tails (Figure 2) (Nobrega et al., 2018).  Phages 




easily observed in laboratory conditions by the formation of plaques on lawns of 




Figure 2. Double-stranded DNA tailed phages. (a) Myoviridae family (b) Siphoviridae 
family (c) Podoviridae family. Both siphophages and myophages have baseplates at the 
distal end of the tail that attach to receptor-binding proteins (RBPs), such as tail fibers and 
tail spikes. Podo phages do not have baseplate, therefore the RBPs attaches directly to the 




Phages recognize and attach to specific receptors on the bacterial surface such as 
the liposaccharides (LPS), oligosaccharides or outer membrane proteins (Chaturongakul 
and Ounjai, 2014) as well as flagella or pili (Koskella and Taylor, 2018). Phage adsorption 
on host cell surface is a two- stage process: reversible and irreversible binding. The 
molecular mechanisms of interaction at both stages are specific to different phage-host 
systems and may vary significantly in representatives of diverse taxonomy groups. 
Adsorption rate is characteristic of each phage-host pair and varies depending on 




the irreversible adsorption phase. Electrochemical membrane potential, ATP molecules, 
enzymatic splitting of peptidoglycan layers, or all three factors may be vital for this 
process. Mechanisms of penetration are specific for each phage or phage groups (Rakhuba 
et al., 2010).  
There are two known life cycles that a phage can undergo once it injects its genetic 
material into host cell: lytic or lysogenic (Figure 3). In the lytic life cycle, the host cell 
supplies the molecular building blocks and enzymes necessary for phage replication and 
production of new phages particles. The phage encodes proteins such as holin and 
endolysin to lyse host cell from within to release progeny (Doss et al., 2017). However, in 
the lysogenic life cycle, the phage does not lyse the host cell immediately, but integrates its 
genome into the host chromosome as a prophage or can also exist as an episomal element 
such as phage P1 (Yarmolinsky and Sternberg, 1988). This prophage replicates along with 
the bacterial host genome. Prophage elements can be a major source of new genes and, 
often, of new functions in bacterial genomes such as pathogenicity islands, toxins, or super 
infection immunity (Brüssow, 2007; Brüssow et al., 2004).  The lysogenic life cycle exists 
until the prophage is induced, often in response to host stress. Prophages are canonically 
induced when antibiotic treatment, oxidative stress, or DNA damage activates the bacterial 
SOS response (Penadés et al., 2015). Upon induction, the prophage excises from the host 
genome and activates its replication cycle; the expression of phage DNA follows, and the 
lytic cycle begins (Doss et al., 2017).   





Figure 3. The two life cycles of a phage. White arrows show the lytic life cycle, and the 
grey arrows show the lysogenic cycle. After infecting the cell, a decision between lytic or 
lysogenic will be determined by the phage shortly. In the lytic cycle, new phage particles 
are produced and released upon host cell lysis. In the lysogenic cycle, phage DNA is 
integrated into host genome or existed as an episomal element, and replicated together with 
the host chromosome when cell division occurs (Figure adapted from Doss et al., 2017). 
 
 
Bacteriophages as biocontrol agents 
Phages were discovered independently by Frederick Twort in 1915 and Felix 
d’Herelle in 1917 and were immediately recognized as potential antimicrobial agents 
(Duckworth, 1976). The capability of phages to kill host cells at the end of the infectious 
cycle is the cornerstone of the idea of using phages as therapeutic agents (Skurnik and 
Strauch, 2006). Lytic phages can provide specific, nontoxic antimicrobial action against 
specific target bacterial pathogens (Koskella and Taylor, 2018). The isolation of phages is 
fast, relatively simple, and inexpensive (Parasion et al., 2014). Phages can stay infective 
under harsh environmental conditions and tend to replicate indefinitely, as long as 




biocontrol agents possess advantages over chemical controls in that tailor-made cocktails 
of different phages can be adapted to target specific disease-causing bacteria, and to 
combat bacterial resistance, which may develop over time (Buttimer et al., 2017). 
Furthermore, the lack of chemical control options and the increases in antibiotic resistance 
in many plant pathogens combined with consumer preference for organic and antibiotic-
free products has led to a phage therapy renaissance in agriculture (Svircev et al., 2018). 
Over the years, multiple phage-phytopathogen-plant systems have been studied, and 
promising results are beginning to emerge (Frampton et al., 2012).  Thus, bacteriophages 





CHAPTER II  
ISOLATION AND CHARACTERIZATIONS OF PHAGES 
 
Introduction  
As previously stated, phages are the most numerous and most diverse life forms on 
earth, therefore environmental samples that include water, plants and soil were directly 
assayed and/or enriched using Xac strains to isolate phages. The objective of the study was 
to isolate virulent phages for Xac, since only virulent and non-transducing should be 
implemented  for the development of an effective and sustainable phage-based control 
system (Gill and Hyman, 2010). The term virulent simply means that each phage-infected 
cell generates progeny phage particles and undergoes lysis. In addition, Gill and Hyman 
(2010) suggested that temperate phages should be avoided when using phage as biocontrol 
agents to achieve therapeutic purpose (Gill and Hyman, 2010). Critical parameters that 
affect phage therapy are phage adsorption rate, burst size and latent period (Payne and 
Jansen, 2001). Latent period, the time between adsorption and cell lysis, determines the 
speed of replication, while burst size represents average production of virions per infected 
cell (Abedon, 2009). Larger burst sizes and lower latent periods will produce more virions, 
which are beneficial in phage treatments (Gill and Hyman, 2010).  However, temperate 
phages may carry harmful genes, thus a full annotation of the phage genome sequence is 
needed to determine the life style of phage  to be used as a biocontrol prevent possible 






Materials and methods 
Phage isolation  
Environmental samples including water, soil, and weeds were collected and 
processed to isolate phages. Soil samples (10 g) were mixed with 20 ml of 0.125 M 
phosphate buffer, pH 7.1, amended with 1% peptone (final concentration). This mixture 
was shaken for 18 h at 28º C, 150 rpm in a 100 ml Erlenmeyer flask, centrifuged at 9,168 x 
g for 20 min at 5º C and filtered through a 0.22 μm filter. The filtrate (soil extract) was 
stored at 4º C. For weed samples, 10 g of chopped plant tissue was added in 20 ml of 
phosphate buffer and processed using a Waring blender. The sample was filtered through 
double-layered cheese cloth to remove plant tissue, centrifuged at 9,168 x g for 20 min at 
5º C and filtered through 0.22 μm filter. The extract was stored at 4º C. Water samples (50 
ml of each) were centrifuged, filter sterilized (0.22 μm) and stored as stated above.  
Phage enrichments were conducted by adding plant, soil or water filtrates to mid-
log broth cultures of Xac isolates and incubating the mixtures. Briefly, the bacterial isolates 
were grown on NBY agar plates (Vidaver, 1967) containing no glucose (MNBY) for 18 h 
at 28º C. The MNBY broth was inoculated with a suspension of freshly grown Xac culture. 
The broth culture (25 ml) was adjusted to a starting OD600 of 0.08, and incubated at 28º C 
(180 rpm). Five ml of each filtrate (soil, weed, or water) was added to the individually 
growing cultures along with five ml of 2x MNBY broth at OD600 = 0.5 (~5 x 10
8 CFU/ml). 
After 18 h, the enrichments were centrifuged at 9,000 x g for 20 min at 5°C. The 
supernatants were filtered through 0.22 μm filter and stored at 4º C.  
The enrichment filtrates were evaluated for phage by spot testing. Twenty µl of a 




supplemented with  1mM MgSO4 (final concentration) that was seeded with 100 µl of 
suspension of  individual Xac strains (OD600 = 0.5). Plates were incubated inverted 
overnight in 28º C and observed for the presence of plaques. Samples resulting in plaques 
were serially diluted and titered using the overlay method. Briefly, 100 μl each of bacterial 
suspension (OD600 = 0.5) and a serial dilution of phage positive enrichments were added to 
the 5ml of 0.4% top agar and overlayed on a MNBY agar plate. Plaques exhibiting 
different morphologies were plaque purified three times using single-plaque purification 
method (Summer et al., 2010). Plaques from the third sub-culture were used to produce 
high titer phage stock lysates using the method of Lysenko et al. (1974). 
Transmission electron microscopy 
The phage samples were negatively stained using a modified Valentine method 
(Valentine et al., 1968). A drop of 50 μl of phage lysate (~ 109 - 1010 PFU/ml) and 2% 
uranyl acetate was pipetted onto pre-cut strip of Parafilm. A small piece of carbon–coated 
mica was dipped into the phage lysate with the carbon film side facing up at a 45 degree 
angle for one minute and then placed onto the drop of 2% uranyl acetate staining for 10 
seconds. A cleaned 300 mesh copper grid was used to pick up the carbon film, and excess 
stain was removed from the side of the grid. The phage morphology was determined by 
using a JEOL1200EX TEM at 100 kV accelerating voltage performed at Texas A&M 
Microscopy and Imaging Center. Images were recorded at calibrated magnifications by the 







Host range study 
A panel of 13 Xac and Xanthomonas sp. were used to determine the host range of 
isolated phages. The strains are listed in Table 2. The host(s) used in the phage 
enrichments were used as the plating control(s) in the study. 
 
Table 2. Host range study test panel. 
Strain ID Genus/species/relevant feature Origin Source 
EC-12 Xanthomonas sp., rice isolate  
(ATCC PTA-13101) 
Texas  (Ahern et al., 
2014) 
EC-12-1 EC-12; unmarked deletion of pilA Texas  (Ahern et al., 
2014) 
North 40 X. axonopodis pv. citri, sweet orange 
isolate 
Florida Wang, N.a 
Ft. Basinger X. axonopodis pv. citri, sweet orange 
isolate 
Florida Wang, N.  
Block 22  X. axonopodis pv. citri, sweet orange 
isolate 
Florida Wang, N.  
306 X. axonopodis pv. citri, pathotype A  Brazil Hartung, 
J.S.b 
XS2000-00060  X. axonopodis pv. citri, pathotype A  Florida  Jones, D.b 
W-4  X. axonopodis pv. citri, Wellington group 
(AW) 
Florida Jones, D.  
XI2000-00120  X. axonopodis pv. citri, Miami group Florida Jones, D.   
XS1999-00038  X. axonopodis pv. citri, Miami group Florida Jones, D.   
XS2003-00004  X. axonopodis pv. citri, Manatee group Florida Jones, D.   
XN2003-0011-1 X. axonopodis pv. citri, Etrog group Florida Jones, D.   
XN2003-0013-2  X. axonopodis pv. citri, Etrog group Florida  Jones, D. 
a University of Florida 




Phage genomic DNA extraction 
The phage lysates of plaque purified phage (>109 PFU/ml) were treated with 
DNase and RNase to final concentration of 2 units/ml at 37º C for 30 mins to degrade the 




(10% w/v PEG-8000, 1M NaCl final concentration) to the lysate at a ratio of 1:2 
(precipitant: lysate), mixed gently by inversion, and incubated for 18-24 h at 4º C.  The 
mixture was centrifuged at 10,000 x g, 4º C for 10 min and the supernatant was discarded. 
The pellet was resuspended in 500 µl of 5 mM MgSO4 and transferred to a new labeled 1.5 
ml microcentrifuge tube. This sample was centrifuged for 5-10 sec to pellet any insoluble 
particles and the supernatant transferred to a new 2 ml microcentrifuge tube. One ml of 
resin from Promega Wizard Kit (Cat. No: A7280) was added to the phage suspension and 
mixed by inverting the tube 5-6 times. The DNA extraction was performed using the 
protocol provided with the kit. Phage DNA was stored at -20 ºC. 
Phage genome sequencing and annotation 
Phage DNA was sequenced using the Illumina MiSeq platform to generate paired-
end 250 bp reads according to manufacturer’s guidelines. FastQC 
(bioinformatics.babraham.ac.uk), FastX Toolkit (hannonlab.cshl.edu), and SPAdes 3.5.0 
(Bankevich et al., 2012) were used for read quality control, read trimming, and read 
assembly, respectively. The completed contig was confirmed via PCR off the genome ends 
with phage specific primer sets (Table 3). The product of PCR amplification was 
sequenced by Sanger sequencing (Eton Bioscience, San Diego, CA). The contig sequence 
was manually corrected to match the resulting Sanger sequencing reads. Genes were 
predicted using Glimmer3 (Delcher et al., 1999) and MetaGeneAnnotator (Noguchi et al., 
2008); and their functions were assigned using InterProScan (Jones et al., 2014), BLAST 
(Camacho et al., 2009) and other tools available in the Web Apollo instance (Lee et al., 
2013) hosted by the Center for Phage Technology (CPT) (https://cpt.tamu.edu/galaxy), and 




Table 3. Primers used in Chapter II for closing the assembled genomes. 
Primer  Sequence  Reference 
CCP504-End-F 5’-ACCTATAGCACACAGTGCCG-3’ This study 
CCP504-Beg-R 5’-GGCTTCCCGTTACACCCTAC-3’ This study 
CCP513-End-F 5’-GGGACCCGGACAACGAATAC-3’ This study 
CCP513-Beg-R 5’-CGCCGAAGTTGTCCAGGTTG-3’ This study 
CCP509-End-F 5’-GTGCAATCCTGACACCGCTG-3’ This study 




Adsorption assay  
Liquid culture of logarithmically growing cells (OD600 ~ 0.5) was mixed with 
individual phage at an MOI ~ 0.1. The mixture was incubated at 28 ºC with shaking (~150 
rpm). Samples of unabsorbed phages were taken at 3 min intervals and immediately filter 
sterilized. The supernatant were serial diluted and plated for plaque count. The rate of 
phage adsorption is defined as dP/dt = -kBP, where k is adsorption constant in ml cell-1 
min-1 , B is the bacteria concentration, and P is the free phage concentration at time of 
interest (Schwartz, 1975). 
One-step growth curve 
The one step growth curve is the standard method used in defining the latent period 
and the average burst size for phage characterization (Delbrück, 1945). Liquid culture of 
logarithmically growing cells (OD600 = 0.5) was mixed with individual phage at an MOI of 
~ 0.1 at 28º C for 5 minutes. After 5 min of adsorption, the phage mixture was diluted 
1000-fold to stop further adsorption (defined as flask A). Flask A was then diluted another 
100-fold (defined as flask B). Both flasks were incubated immediately at 28º C with 
constant shaking (150 rpm). Samples were taken at 3-min intervals and plated for plaque 




lysis. The period between initial adsorption and the sudden increase was defined as latent 
period. The plaque count at cell lysis divided by adsorbed phage count was defined as 
burst size.   
Microtiter plate assay  
A single colony in overnight broth culture of Xac (strain Block 22) was diluted and 
adjusted to OD600 = 1.0 (~ 10
9 CFU/ml) spectrophotometrically with MNBY broth, then 
used as inoculum for loading into Falcon 96 well flat bottom plate (Corning, Cat. No. 
351172). Phage lysates were tittered and adjusted with P-buffer (50 mM Tris-HCl pH 7.5, 
100 mM NaCl, 8 mM MgSO4) to the desire concentation of 107, 108, 109 PFU/ml prior 
loading on the plate. For each well, 160 µl of MNYB broth was added along with 20 µl of 
Xac (~ 108 CFU/ ml final concertation) and 20 µl of phage (~ 106, 107and 108 PFU/ml final 
concentration) to achieve multiplicity of infection (MOI) of 0.1, 1 and 10, respectively. 
The plate was incubated at 28º C with double orbital shaking at 150 rpm in a Tecan Spark 
10 M plate reader (Tecan Group Ltd., Männedorf, Switzerland). The growth was 
monitored at 30 min intervals for 20 h by measuring OD600. After baseline adjustment, 
growth curves were generated by plotting OD600 measurements against time. All assays 
were done in triplicate.    
Results and discussion  
Phages isolation and characterization  
Thirty nine phages were isolated from enriched sewage water and plant filtrates 
using Xanthomonas EC-12 or Xac sweet orange isolates as the host. The phages were then 




in Table 2. Three phages with different morphologies and host range groups were chosen 
for further characterization. The phages were designated CCP504, CCP513, and CCP509.  
Phage CCP504 was isolated from a water sample collected at Wolf Pen Creek in 
College Station, Texas, using Xac strain Ft. Basinger as host for enrichment. Phages 
CCP505 and CCP511 were isolated from water samples collected at  Lick Creek and Cater 
Creek waste water treatment plants located in College Station and Bryan, Texas,  
respectively, using EC-12 as host for enrichment. Phages CCP513 and CCP509 isolated 
from sewage water samples collected from the Carter Creek and Lick Creek waste water 
treatment plants located in Bryan and College Station, Texas, respectively, using Xac strain 
Block 22 as the host for enrichment.   
The host range and physical properties of the three selected phages are summarized 
in Table 4, 5 and Figure 4. Phage CCP504 exhibited podophage morphology with an 
isometric head of 50 nm in diameter and a short stubby non-contractile tail (Figure 4a, 
Table 5). Phage CCP513 exhibited siphophage morphology with an isometric head of 57 
nm in diameter and a long non-contractile tail of 122 nm in length (Figure 4b, Table 5). 
Phage CCP509 exhibited myophage morphology with an isometric head of 97 nm in 
diameter and a long contractile tail of 149 nm in length (Figure 4c, Table 4). All three 
selected phages formed plaques on Xanthomonas spp. and/or Xac strains with differences 
in their host range (Table 4). The podophage formed large, clear plaques, whereas the 
siphophage and myophage formed small, clear plaques.  
Full characterization was conducted on selected phages CCP504, CCP513 and 
CCP509. However, podophages CCP504, CCP505 and CCP511 and siphophage CCP513 




greenhouse studies (See Chapter IV). The four phages were chosen based on host range 
differences (Table 4), morphology and preliminary annotation of sequenced genomes (data 
not shown).   
 
Table 4. Phages host range. 
Strain ID  Phage designation and host range  
CCP504 CCP505 CCP511 CCP513 CCP509 
EC-12 +a + + - + 
EC-12-1 - - - - - 
North 40 + + + + + 
Ft. Basinger + + + + + 
Block 22  + + + + + 
306 - - - - - 
XS2000-00060  - - - - - 
W-4  + - - + + 
XI2000-00120  + + + + + 
XS1999-00038  + + + + + 
XS2003-00004  - - - - - 
XN2003-0011-1 - - + - + 
XN2003-0013-2  - - + - + 





Figure 4. Phage TEM image of selected phages. (a) CCP504, (b) CCP513, (c) CCP509. 
Samples were negatively stained with 2% (wt/vol) aqueous uranyl acetate. Additional 
information is shown in Table 5. 
 
   




Table 5. General, physiological, and structural characteristics of Xac phages.  
 CCP504 CCP513 CCP509 
 Morphology  Podo Sipho Myo 
 Capsid width (nm) 50 57 97 
 Tail length (nm) - 122 149 
 Mean k (ml cell-1 min-1)  1.52 x 10-10 1.12 x10-10 2.01 x 10-10 
 Latent period (min) 30 30 21 
 Mean burst size (PFU cell-1) 50 75 48 
 Genome size (kb) 44.5  42.5 199 




 Adsorption constants were determined from three replicate experiments using strain 
Block 22 as host.  The observed adsorption constants for the three phages were  
1.52 x 10-10, 1.21 x 10-10 and 2.01 x 10-10 ml cell-1 min-1, for CCP504, CCP513 and 
CCP509, respectively. An average burst size of three phages were between 50-75 PFU cell-
1 at approximately 30 min for CCP504 and CCP513 and 21 min for CPP509  
(Table 5). 
Liquid infection assays  
The efficacy of CCP504, CCP513, and CCP509 against Xac strain Block 22 in 
liquid culture were assessed at MOIs of 0.1, 1 and 10 within a time frame of 20 h (Figure 
5). The result of this assay showed significant suppression of Xac Block 22, when phages 
were added compared to the bacterial control at all tested MOI. However, phage CCP504 
showed little variation in the growth suppression of Block 22 (Figure 5a). In contrast, 
CCP513 and CCP509 are dependent on the MOI used, as MOI increased, the growth of the 





   
Figure 5. Phage ability to kill Xac strain Block 22 cells in liquid culture at different MOIs 
(a) Block 22 vs. CCP504 (b) Block 22 vs. CCP513 (c) Block 22 vs. CCP513. The 
experiments were performed in triplicate, bars indicate standard deviation.  
 
 
Phage genomes analysis  
Phage CCP504 
CCP504 is a podophage with a 44,551 bp genome, a coding density of 96.4% and a 
G+C content of 62.4%. Genome annotation revealed 59 protein coding sequences, of 
which 26 have a predicted function as determined by BLASTp and InterProScan. Using 
PhageTerm (Garneau et al., 2017), a nonpermutated direct terminal repeat of 405 bp was 
predicted. CCP504 shared 79.97, 77.92, and 71.84% nucleotide sequence identity with 
Xanthomonas phage f30-Xaj (KU595433.1), Xanthomonas phage f20-Xaj (KU595432.1), 




(Darling et al., 2004). CCP504 is phiKMV-like based on the genomic orientation and 
protein homology range from 36 to 86% with other phiKMV-like phages (Ahern et al., 
2014; de Leeuw et al., 2017; Lavigne et al., 2003). Similar to other phiKMV-like phages, 
phage CCP504 contains a single subunit RNA polymerase (RNAP) at the end of class II 
gene cluster of DNA metabolism. CCP504 metabolism genes follow the order of phiKMV-
like phages: DNA primase, DNA helicase, DNA polymerase, ribonuclease H-like 
superfamily, DNA ligase, and RNAP. In the lysis cassette of CCP504 the holin gene is 
found upstream of the endolysin, separated by terminase small subunit, terminase large 
subunit and a hypothetical protein, respectively. The holin gene belongs to class III holin 
consist with a single transmembrane domain (TMD). The endolysin showed characteristic 
of a SAR endolysin that exhibits an N-terminal hydrophobic domain rich in weakly 
hydrophobic residues (Xu et al., 2004b). A Glycoside hydrolase, family 24 (IPR002196) is 
predicted by InterProScan and contains an E-8 aa-D-5 aa-T catalytic triad, a characteristic 
of true lysozymes found in T4 protein E (Kuty et al., 2010). CCP504 also encodes the two 
component spanins, which has the o-spanin partially embedded in the i-spanin, resulted in 
the disruption of the outer membrane in Gram negative host. 
The genomes of two other podophages (CCP505 and CCP511) were also partially 
annotated (data not shown).  Both phages were determined to be phiKMV-like phages, 
since both they encode a single-subunit RNA polymerase (RNAP) at the end of the class II 
gene cluster rather than in the early genomic region (Lavigne et al., 2003). Although not 






Figure 6. CCP504 genome map.
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Table 6. CCP504 putative genes and homologues. 
GPa Name Start End Strand Length (AAb) Representative homologue E value 
gp1 Hypothetical protein 704 966 + 84 
  
gp2 Hypothetical protein 949 1109 + 49 
  
gp3 Hypothetical protein 1132 1699 + 186 A0A249XLE5_9CAUD Uncharacterized protein 
OS=Xanthomonas phage phi Xc10 
1.70E-117 
gp4 Hypothetical protein 1685 1944 + 82 
  
gp5 Hypothetical protein 1894 2857 + 317 
  
gp6 Hypothetical protein 2907 3048 + 42 
  
gp7 Hypothetical protein 3001 3262 + 82 
  
gp8 Hypothetical protein 3242 3794 + 180 
  
gp9 Hypothetical protein 3776 4065 + 93 
  
gp10 Hypothetical protein 4053 4457 + 130 
  
gp11 Hypothetical protein 4444 4642 + 63 
  
gp12 Hypothetical protein 4629 4977 + 113 
  
gp13 Hypothetical protein 5038 5505 + 151 
  
gp14 Hypothetical protein 5489 5753 + 84 
  
gp15 DNA primase 5759 6590 + 274 V5Q8P0_9CAUD DNA primase 6.66E-170 
gp16 Hypothetical protein 6573 6817 + 77 
  
gp17 DNA Helicase 6795 8093 + 429 IPR027417 2.90E-04 
gp18 Hypothetical protein 8079 8407 + 106 
  
gp19 Hypothetical protein 8389 8850 + 149 
  
gp20 DNA Polymerase 8836 11312 + 822 NP_041982.1 T7_gene_5 DNA polymerase A ,  
IPR001098 
5.43E-10 
gp21 Hypothetical protein 11311 12220 + 298 
  
gp22 5'-3' Exonuclease 12207 13149 + 310 IPR020045 5.53E-11 
gp23 Recombination 
endonuclease VII 




Table 6. Continued 
GP Name Start End Strand Length (AA) Representative homologue E value 
gp24 3'-5' exonuclease 13518 14356 + 276 IPR012337 2.23E-16 
gp25 hypothetical protein 14355 14944 + 193 
  
gp26 hypothetical protein 14915 15143 + 71 
  
gp27 hypothetical protein 15133 15352 + 70 
  
gp28 hypothetical protein 15341 15661 + 103 
  
gp29 hypothetical protein 15638 15854 + 67 
  
gp30 DNA ligase 15837 16813 + 321 DNLI_NATPD DNA ligase 3.57E-04 
gp31 hypothetical protein 16797 16977 + 56 
  
gp32 hypothetical protein 16966 17231 + 85 
  
gp33 DNA-directed RNA 
polymerase 
17223 19743 + 837 NP_041960.1 T7_gene_1 RNA polymerase , 
IPR002092 
4.81E-106 
gp34 hypothetical protein 19850 20070 + 70 
  
gp35 hypothetical protein 20020 20506 + 157 
  
gp36 hypothetical protein 20497 20857 + 116 
  
gp37 head-tail connector 
protein 
20855 22397 + 511 NP_041995.1 T7_gene_8 head-tail connector protein , 
IPR020991 
1.88E-48 
gp38 scaffold protein 22378 23245 + 284 V5Q8R0_9CAUD Scaffold protein 6.47E-101 
gp39 major capsid protein 23251 24272 + 335 NP_041998.1 T7_gene_10A major capsid protein, 4.04E-04 
gp40 hypothetical protein 24336 24564 + 72 
  
gp41 tail tubular protein A 24611 25239 + 206 NP_041999.1 T7_gene_11 tail tubular protein A, 
IPR033767 
3.82E-11 
gp42 tail tubular protein B 25238 27753 + 835 NP_042000.1 T7_gene_12 tail tubular protein B 2.25E-12 
gp43 putative internal virion 
protein 
27739 28637 + 295 V5Q8R5_9CAUD Internal virion protein 8.63E-154 
gp44 putative internal virion 
protein 




Table 6. Continued 
GP Name Start End Strand Length (AA) Representative homologue E value 
gp45 putative internal 
virion protein 
30993 35916 + 1637 IPR023346 1.10E-13 
gp46 tail fiber protein 35964 37096 + 374 IPR005604 1.90E-07 
gp47 tail fiber protein 37088 38310 + 404 V5Q9R3_9CAUD Tail fiber protein 0 
gp48 tail fiber protein 38296 39251 + 315 V5Q8S0_9CAUD Tail fiber protein 0 
gp49 tail fiber protein 39231 39829 + 194 V5Q7S0_9CAUD Tail fiber protein 8.73E-137 
gp50 holin 39834 40046 + 67 V5Q7X0_9CAUD Holin OS=Xylella phage Prado 8.83E-33 
gp51 terminase small 
subunit 
40016 40317 + 97 V5Q7T5_9CAUD Terminase small subunit 4.44E-35 
gp52 terminase large 
subunit 
40292 42118 + 603 NP_042010.1 T7_gene_19 terminase large subunit 7.22E-81 
gp53 hypothetical protein 42110 42368 + 83 
  
gp54 endolysin 42357 42923 + 184 ENLYS_BPKMV SAR Endolysin OS=Pseudomonas 
phage phiKMV, IPR002196 
2.31E-17 
gp55 i-Spanin 42887 43222 + 107 V5Q7X5_9CAUD i-spanin 2.94E-04 
gp56 o-Spanin 43109 43421 + 100 V5Q7T9_9CAUD o-spanin 2.13E-13 
gp57 hypothetical protein 43408 43849 + 144 IPR029055 3.09E-07 
gp58 hypothetical protein 43881 44157 + 92 
  
gp59 hypothetical protein 44186 44306 + 37 
  
 a GP = Gene products 




CCP513 is a siphophage with a 42,598 bp genome, a coding density of 94.6% and a 
G+C content of 62.6%. Genome annotation revealed 56 protein coding sequences, of 
which 33 have a predicted function as determined by BLASTp and InterProScan and no 
predicted tRNAs. Using PhageTerm (Garneau et al., 2017), a headful packaging was 
predicted. Progressive MAUVE algorithm (Darling et al., 2004) showed approximately 
19% DNA sequence similarity to others Pseudomonas phages in the NCBI nucleotide 
database including vB_PaeS_PAO1_Ab18 (LN610577.1),  vB_PaeS_PAO1_Ab20 
(LN610585.1), PaMx11 (JQ067087.2) and AAT-1 (KU204984.2).  At protein level, 
CCP513 shared 28, 29, and 30 unique proteins with Vibrio phage VpKK5 (KM378617.2), 
Pseudomonas phage NP1 (KX129925.1) and Pseudomonas phage PaMx25 (JQ067084.3), 
respectively. Genes related to DNA morphogenesis and metabolism were identified. 
Unlike CCP504 and CCP509, the lysis cassette of CCP513 includes the endolysin (D-
alanyl-D-alanine carboxypeptidases), holin and two component spanins identified in a 
cluster. The holin gene belonged to class I holin consist with three TMDs with N-out, C-in 
topology. The o-spanin gene is partially embedded in the i-spanin gene. Tail assembly 
chaperone with a frameshifted protein product is followed by the tape measure protein 







Figure 7. CCP513 genome map.
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Table 7. CCP513 putative genes and homologues. 
GPa Name Start End Strand Length (AAb) Representative homologue E value 
gp1 terminase small 
subunit 
3 542 + 176 IPR005335 1.20E-07 
gp2 terminase large 
subunit 
528 2034 + 502 A0A1X9IAM3_9CAUD Terminase large subunit 
OS=Xanthomonas phage Xoo-sp2  
 
gp3 portal protein 2033 3553 + 503 H6WTZ6_9CAUD Portal protein OS=Pseudomonas phage 
vB_Pae-Kakheti25 , IPR025129 
5.21E-173 
gp4 hypothetical protein 3606 3794 + 57   
 
gp5 head morphogenesis 3770 4848 + 355 IPR006528, 8.90E-10 
gp6 putative scaffold 
protein 
4877 5600 + 241 A0A0M3MWV9_9CAUD Scaffold protein 
OS=Stenotrophomonas phage vB_SmaS-DLP_2 
2.37E-46 
gp7 major capsid protein 5588 6562 + 320 A0A0M3WLU8_9CAUD Major capsid protein 
OS=Stenotrophomonas phage vB_SmaS-DLP_2 
7.00E-142 
gp8 hypothetical protein 6605 6944 + 109   
 
gp9 hypothetical protein 6943 7456 + 167 I6NRE5_9CAUD Uncharacterized protein OS=Burkholderia 
phage KL1 
4.13E-33 
gp10 hypothetical protein 7439 7809 + 119   
 
gp11 hypothetical protein 7795 8204 + 133 YP_003902.1 T1_gp43 hypothetical protein 1.99E-09 
gp12 tail terminator protein 8188 8608 + 136 A0A0S0MVB0_9CAUD Tail terminator protein 
OS=Pseudomonas phage PaMx28 , IPR025395 
6.56E-35 
gp13 major tail structural 
protein 
8610 9562 + 313 A0A0S0N828_9CAUD Major tail structural protein 
OS=Pseudomonas phage PaMx11 
4.39E-170 
gp14 tail assembly 
chaperone  
9548 10038 + 308 IPR014859 1.40E-05 
gp15 tail assembly 
chaperone frameshift 
product 
10007 10280 + 91   
 
gp16 putative tape measure 
protein 
10254 12729 + 822 TMP_BPPAJ Probable tape measure protein 






Table 7. Continued 
GP Name Start End Strand Length (AA) Representative homologue E value 
gp17 virion structural 
protein 
12728 14268 + 510 A0A0S0N8F3_9CAUD Virion structural protein 
OS=Pseudomonas phage PaMx25, IPR008979 
0 
gp18 putative virion protein 14268 15281 + 334 A0A0S0MWN7_9CAUD Putative virion structural protein 
OS=Pseudomonas phage PaMx74 
1.21E-158 
gp19 distal tail protein 15270 16944 + 554 YP_009101121.1, Salmonella phage Chi 2.10E-23 
gp20 putative virion protein 16928 17750 + 270 A0A0S0ND36_9CAUD Putative virion structural protein 
OS=Pseudomonas phage PaMx11, IPR019228 
9.31E-165 
gp21 hypothetical protein 17748 17993 + 78 YP_009101121.1, Salmonella phage Chi 1.88E-05 
gp22 hypothetical protein 17978 18196 + 69 A0A2H4GXX9_9CAUD Uncharacterized protein 
OS=Pseudomonas phage JG012  
1.51E-26 
gp23 minor tail protein 18168 20351 + 724 YP_009101121.1, Salmonella phage Chi, IPR032876 1.46E-111 
gp24 tail fiber protein 20339 20707 + 119 YP_009101121.1, Salmonella phage Chi,IPR021251 5.76E-19 
gp25 hypothetical protein 20735 20993 - 82 A0A0M3MYX9_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage vB_SmaS-DLP_2 
2.66E-05 
gp26 hypothetical protein 20992 21158 - 51   
 
gp27 DNA polymerase 21229 23254 - 671 IPR001098 2.70E-62 
gp28 putative replicative 
clamp 
23238 24201 - 317 A0A0S0N5L1_9CAUD Putative replicative clamp 




24188 25124 - 307 Queuosine tRNA-ribosyltransferase OS=Vibrio phage 
VpKK5 
1.38E-110 












27296 28010 - 234 A0A0E3M1C4_9CAUD Queuosine Biosynthesis QueE 







GP Name Start End Strand Length (AA) Representative homologue E value 
gp34 hypothetical protein 28117 28447 - 106 A0A2I7R531_9VIRU Uncharacterized protein OS=Vibrio 
phage 1.117.O._10N.261.45.E9 
1.02E-28 
gp35 hypothetical protein 28536 29228 - 227 A5A3S9_9CAUD BcepGomrgp40, Burkholderia phage 
BcepGomr  
1.21E-04 
gp36 hypothetical protein 29229 29775 - 178 A0A088FAK6_9CAUD Uncharacterized protein OS=Vibrio 
phage VpKK5 
5.14E-15 




30077 31769 - 559 YP_003923.1 T1_gp22 putative ATP-dependent helicase, 
IPR006935, IPR001650 
3.07E-16 
gp39 putative exonuclease 31755 32728 - 320 A0A172PZV2_9CAUD Putative exonuclease 
OS=Pseudomonas phage NP1, IPR011604 
7.32E-117 
gp40 hypothetical protein 32714 33264 - 179   
 
gp41 hypothetical protein 33216 33750 - 173 IPR021686 4.40E-37 
gp42 hypothetical protein 33713 34456 - 243 IPR007731 9.80E-18 
gp43 putative RecA 
ATPase 
34443 35141 - 228 A0A0S0N5J7_9CAUD Putative RecA ATPase 
OS=Pseudomonas phage PaMx25, IPR027417 
1.88E-113 
gp44 hypothetical protein 35127 35393 - 85   
 
gp45 hypothetical protein 35385 35808 - 137 A0A0S0N8R3_9CAUD Uncharacterized protein 
OS=Pseudomonas phage PaMx25 GN=PaMx25_56 
8.11E-31 
gp46 hypothetical protein 35938 36163 + 70 A0A088F6R6_9CAUD Uncharacterized protein OS=Vibrio 
phage VpKK5  
1.19E-06 
gp47 primase/helicase 36153 38388 + 741 A0A088FAP0_9CAUD Primase/helicase OS=Vibrio phage 
VpKK5  
1.89E-180 
gp48 hypothetical protein 38700 39141 + 143 A0A088F6R6_9CAUD Uncharacterized protein OS=Vibrio 
phage VpKK5 
4.37E-27 
gp49 hypothetical protein 39188 39906 + 236 IPR024498 2.40E-14 
gp50 hypothetical protein 39932 40268 + 108 A0A172Q030_9CAUD Uncharacterized protein 
OS=Pseudomonas phage NP1  
3.79E-24 






Table 7. Continued 
GP Name Start End Strand Length (AA) Representative homologue E value 
gp52 hypothetical protein 40419 40617 + 61 A0A172PZW8_9CAUD Uncharacterized protein 
OS=Pseudomonas phage NP1 
2.49E-09 
gp53 putative nucleotide 
triphosphate 
hydrolase 
40588 41141 + 180 A0A0S0N575_9CAUD Putative nucleotide triphosphate 




41200 41617 + 135 ENLYS_BPT5 L-alanyl-D-glutamate peptidase 
OS=Escherichia phage T5 
1.01E-15 
gp55 holin 41607 41983 + 121 YP_001542615.1 Enterobacteria phage PRD1, IPR032126 4.97E-11 
gp56 i-spanin 41938 42353 + 134   
 
gp57 o-spanin 42257 42531 + 88   
 
a GP = Gene products 




CCP509 is a myophage with a 199,186 bp genome, a coding density of 91% and a 
G+C content of 50.2%. Genome annotation revealed 328 protein coding sequences, of 
which 87 have a predicted function as determined by BLASTp and InterProScan, and 41 
tRNAs were identified with ARAGORN 2.36 (Laslett and Canback, 2004) . Using 
PhageTerm (Garneau et al., 2017), a headful packaging was predicted. Progressive 
MAUVE algorithm (Darling et al., 2004) showed  little recognizable DNA sequence 
similarity to other phages in NCBI nucleotide database, less than 7%. However, at protein 
level, CCP 509 shared 87 and 74 unique proteins with Stenotrophomonas phage IME-SM1 
(KR560069.1) and Acidovorax phage ACP17 (KY979132.2), respectively. CCP509 is a 
T4-like phage with 45 proteins that are homologous with phage T4 as resulted by BLASTp 
with E value < 10-5. Majority of morphogenesis, DNA replication and repair genes of 
CCP509 were identified. Genes for biosynthesis proteins were also found such as 
ribonucleoside-diphosphate reductase alpha and beta, deoxynucleoside monophosphate 
kinase and NAD/GMP synthase, and queuosine biosynthesis QueE radical SAM etc. And 
similar to T4, the lysis cassette does not cluster together. A glycoside hydrolase type of 
endolysin (IPR023346) was found upstream from the spanin complex in the 75-80 kb 
range. The spanins complex contains o-spanin embedded in the i-spanin. However, we 
were not able identify the location of the holin gene in the genome because there are 
several genes with TMHMM prediction utilizing for holin classification but did not have 




Figure 8. CCP509 genome map.
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Table 8. CCP509 putative genes and homologues, and tRNAs predictions. 
GPa Name Start End  Strand Length (AAb)  Representative homologue  E value  
gp1 putative nicotinate 
phosphoribosyltransferase 
98 1552 + 481 YP_009041424.1 K_gp064 putative nicotinate 
phosphoribosyltransferase, IPR007229 
3.20E-64 
gp2 hypothetical protein 1577 1809 + 74     
gp3 hypothetical protein 1775 1972 + 62     
gp4 hypothetical protein 1959 3288 + 439 A0A1Y5SJ14_9RHOB Uncharacterized protein 
OS=Pseudooctadecabacter jejudonensis 
1.64E-18 
gp5 hypothetical protein 3271 3553 + 91     
gp6 hypothetical protein 3606 3858 + 84     
gp7 hypothetical protein 4342 4804 + 154 A0A292GDH9_9VIRU Uncharacterized protein 
OS=Xanthomonas phage XacN1 
3.26E-30 
gp8 hypothetical protein 4847 5131 + 91 Q8SD46_BPDPK PHIKZ116 OS=Pseudomonas 
phage phiKZ  
4.23E-11 
gp9 hypothetical protein 5119 6081 + 317 A0A0H4ISK8_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage IME-SM1  
2.73E-134 
gp10 hypothetical protein 6058 6295 + 75     
gp11 hypothetical protein 6282 6486 + 64     
gp12 hypothetical protein 6478 6694 + 69     
gp13 hypothetical protein 6676 6945 + 85 A0A1B4XX76_9VIRU Uncharacterized protein 
OS=Tenacibaculum phage pT24 
5.41E-12 
gp14 hypothetical protein 6929 7172 + 77 A0A258ANU9_9BACT Uncharacterized protein 
OS=Verrucomicrobia bacterium 12-59-8 
3.03E-07 
gp15 hypothetical protein 7158 7351 + 60     
gp16 hypothetical protein 7338 7569 + 73     
gp17 hypothetical protein 7571 8175 + 198 YFDR_ECOLI Uncharacterized protein YfdR 
OS=Escherichia coli (strain K12) 
1.33E-37 
gp18 hypothetical protein 8199 8553 + 115 A0A0H4ISN2_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage IME-SM1 
3.28E-12 
gp19 hypothetical protein 8518 8726 + 65     
gp20 hypothetical protein 8684 8913 + 73     
gp21 hypothetical protein 8907 9117 + 67 A0A218M346_9VIRU Uncharacterized protein 





Table 8. Continued 
GP Name Start End  Strand Length (AA)  Representative homologue  E value  
gp22 hypothetical protein 9104 9271 + 51     
gp23 hypothetical protein 9283 9568 + 92     
gp24 hypothetical protein 9992 10399 + 132     
gp25 hypothetical protein 10385 10608 + 71 A0A023NP49_9GAMM Uncharacterized protein 
OS=Dyella jiangningensis 
1.85E-05 
gp26 hypothetical protein 10594 11132 + 176 A0A0E3FWE4_9CAUD Uncharacterized protein 
OS=Synechococcus phage ACG-2014f 
2.37E-06 
gp27 hypothetical protein 11137 11449 + 100     
gp28 hypothetical protein 11439 11793 + 114     
gp29 hypothetical protein 11784 11996 + 67 A0A0F9RYF5_9ZZZZ Uncharacterized protein 
OS=marine sediment metagenome  
2.20E-05 
tRNA tRNA-Val 11996 12072 + 0     
tRNA tRNA-Leu 12078 12155 + 0     
tRNA tRNA-Leua 12245 12323 + 0     
gp30 hypothetical protein 12314 12505 + 60     
tRNA  tRNA-Thr 12467 12542 + 0     
tRNA  tRNA-Met 12548 12624 + 0     




13037 15367 + 773 NP_049845.1 T4_gene_nrdA ribonucleoside-
diphosphate reductase subunit alpha, IPR000788 
2.54E-167 
gp33 hypothetical protein 15320 15515 + 60     
gp34 nrdB aerobic NDP 
reductase, small subunit 
15500 16600 + 363 NP_049841.1 T4_gene_nrdB NrdB aerobic NDP 
reductase, small subunit, IPR000358 
7.14E-64 
gp35 hypothetical protein 16563 16967 + 130 IPR021686 1.60E-34 
gp36 glutaredoxin 16945 17184 + 75 IPR002109 1.10E-11 
gp37 hypothetical protein 17451 18558 + 366 A0A0H4IPU2_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage IME-SM1  
1.28E-29 
gp38 hypothetical protein 18604 18812 + 66     




Table 8. Continued 
GP Name Start End  Strand Length (AA)  Representative homologue  E value  
gp40 hypothetical protein 19271 19792 + 170 A0A218M399_9VIRU Uncharacterized protein 
OS=Acidovorax phage ACP17 
2.03E-38 
gp41 hypothetical protein 19777 20097 + 103     
gp42 hypothetical protein 20441 20731 + 93     
gp43 DNA ligase 20770 22075 + 432 NP_049813.1 T4_gene_30 DNA ligase, 
IPR012310 
2.24E-63 
gp44 hypothetical protein 22173 22443 + 85     
gp45 hypothetical protein 22464 22744 + 90     
gp46 hypothetical protein 22731 22995 + 84     
gp47 hypothetical protein 23007 23304 + 95     
gp48 hypothetical protein 23291 23612 + 103     
gp49 hypothetical protein 23596 24094 + 161     
gp50 hypothetical protein 24090 24543 + 151     
gp51 hypothetical protein 24823 24950 + 39     
tRNA  tRNA-Trp 25058 25132 + 0     
tRNA  tRNA-Cys 25214 25290 + 0     
tRNA  tRNA-Pro 25300 25377 + 0     
gp52 hypothetical protein 25335 25532 + 63     
gp53 hypothetical protein 25573 25737 + 50     
tRNA  tRNA-Ala 25573 25648 + 0     
tRNA  tRNA-Alaa 25654 25730 + 0     
tRNA  tRNA-Leuc 25741 25826 + 0     
gp54 hypothetical protein 25775 25961 + 59     
tRNA  tRNA-Lys 26035 26109 + 0     
tRNA  tRNA-Thra 26115 26191 + 0     
tRNA  tRNA-Gly 26271 26345 + 0     
tRNA  tRNA-Glu 26356 26434 + 0     
tRNA  tRNA-Glua 26440 26515 + 0     
tRNA  tRNA-Arg 26521 26598 + 0     




Table 8. Continued 
GP Name Start End  Strand Length (AA)  Representative homologue  E value  
tRNA  tRNA-Tyr 26701 26792 + 0     
tRNA  tRNA-Vala 26800 26875 + 0     
tRNA  tRNA-Gluc 27925 28003 + 0     
tRNA  tRNA-Proa 28245 28322 + 0     
tRNA  tRNA-Asn 28330 28416 + 0     
tRNA  tRNA-Asna 28421 28497 + 0     
tRNA  tRNA-Asp 28506 28581 + 0     
tRNA  tRNA-Aspa 28589 28667 + 0     
tRNA  tRNA-Meta 28761 28836 + 0     
tRNA  tRNA-Lysa 28924 29000 + 0     
tRNA  tRNA-Lysc 29084 29172 + 0     
gp55 hypothetical protein 29176 29467 + 94 A0A218M301_9VIRU Uncharacterized protein 
OS=Acidovorax phage ACP17 
1.25E-04 
gp56 hypothetical protein 29473 29693 + 70     
tRNA tRNA-Lys|Stop 29702 29776 + 0     
gp57 ribonuclease H-like 29850 30336 + 158 IPR007405 6.90E-14 
tRNA tRNA-Leud 30342 30428 + 0     
tRNA tRNA-Phe 30435 30511 + 0     
gp58 hypothetical protein 30563 30762 + 62     
tRNA tRNA-Phea 30785 30860 + 0     
gp59 GroES molecular 
chaperone protein 
30865 31124 + 83 A0A142F037_9VIRU GroES molecular 
chaperone protein OS=Stenotrophomonas phage 
vB_SmaS-DLP_6 
2.78E-14 
tRNA tRNA-His 31138 31215 + 0     
tRNA tRNA-Ile 31223 31298 + 0     
tRNA tRNA-Ilea 31305 31379 + 0     
tRNA tRNA-Gln 31576 31651 + 0     
tRNA tRNA-Glna 31658 31732 + 0     
gp60 hypothetical protein 31987 32109 + 35     




Table 8. Continued 
GP Name Start End  Strand Length (AA)  Representative homologue  E value  
gp62 hypothetical protein 32577 32713 + 41     
gp63 hypothetical protein 32706 32947 + 77     
gp64 hypothetical protein 32931 33261 + 107     
gp65 hypothetical protein 33252 33365 + 33     
gp66 hypothetical protein 33364 33548 + 58     
gp67 hypothetical protein 33596 34072 + 156     
gp68 hypothetical protein 34058 34428 + 119 A0A142F006_9VIRU Uncharacterized protein 
OS=Stenotrophomonas phage vB_SmaS-DLP_6 
2.06E-05 
gp69 hypothetical protein 34418 34655 + 75     
gp70 hypothetical protein 34614 34807 + 60     
tRNA tRNA-Ser 34770 34857 + 0     
gp71 hypothetical protein 34861 35334 + 154 A0A142EZW0_9VIRU Uncharacterized protein 
OS=Stenotrophomonas phage vB_SmaS-DLP_6 
1.39E-24 
gp72 hypothetical protein 35436 35640 + 65     
tRNA tRNA-Thrc 35630 35705 + 0     
gp73 hypothetical protein 35769 35910 + 42     
tRNA tRNA-Glya 35887 35964 + 0     
gp74 hypothetical protein 36034 36522 + 159     
gp75 hypothetical protein 36514 36846 + 108     
gp76 hypothetical protein 36902 37181 + 88     
gp77 hypothetical protein 37164 37471 + 98     
gp78 hypothetical protein 37454 37761 + 98     
gp79 hypothetical protein 37746 38051 + 97     
gp80 hypothetical protein 38031 38329 + 94     
gp81 calcineurin-like 
phosphoesterase 
38296 39083 + 259     
gp82 hypothetical protein 39067 39439 + 120 F8SJR6_9CAUD Uncharacterized protein 034 







Table 8. Continued  
GP Name Start End  Strand Length (AA)  Representative homologue  E value  
gp83 hypothetical protein 39426 39588 + 50     
gp84 hypothetical protein 39580 40572 + 327 A0A0H4IP63_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage IME-SM1 
1.79E-32 
gp85 hypothetical protein 40558 40901 + 111     
gp86 hypothetical protein 40892 41148 + 82     
gp87 hypothetical protein 41265 41929 + 217 |A0A0H4INV0_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage IME-SM1 
2.33E-17 
gp88 phosphohydrolase 42049 42562 + 168 A0A0H4IS72_9CAUD Phosphohydrolase 
OS=Stenotrophomonas phage IME-SM1  
1.02E-45 
gp89 hypothetical protein 42541 43007 + 152     
gp90 hypothetical protein 43007 43240 + 74 A0A142EZZ3_9VIRU Uncharacterized protein 
OS=Stenotrophomonas phage vB_SmaS-DLP_6 
3.72E-14 
gp91 hypothetical protein 43271 43434 + 49     
gp92 DNA topoisomerase II 
large subunit 
43522 45344 + 604 NP_049621.1 T4_gene_39 DNA topoisomerase 
II large subunit , IPR001241 
8.35E-51 
gp93 DNA topisomerase II 
medium subunit 
45331 46705 + 455 NP_049875.1 T4_gene_52 DNA topisomerase II 
medium subunit , IPR002205 
3.06E-57 
gp94 hypothetical protein 46757 47086 + 106     
gp95 hypothetical protein 47072 47355 + 91     
gp96 hypothetical protein 47341 47651 + 100     
gp97 hypothetical protein 47644 47874 + 72     
gp98 hypothetical protein 47863 48172 + 98     
gp99 hypothetical protein 48153 48525 + 119 A0A292GJA5_9VIRU Predicted ORF 
OS=Xanthomonas phage XacN1 
1.12E-09 
gp100 hypothetical protein 48534 49002 + 152 A0A142IDS7_9CAUD Uncharacterized protein 
OS=Pseudomonas phage vB_PsyM_KIL1 
1.40E-13 
gp101 polynucleotide kinase 48988 49892 + 297 NP_049834.1 T4_gene_pseT polynucleotide 
kinase 
1.52E-42 




Table 8. Continued 
GP Name Start End  Strand Length (AA)  Representative homologue  E value  
gp103 hypothetical protein 50172 50404 + 73     
gp104 hypothetical protein 50464 51470 + 330 A0A218M383_9VIRU Uncharacterized protein 
OS=Acidovorax phage ACP17 
4.06E-115 
gp105 hypothetical protein 51469 51726 + 82 A0A142F064_9VIRU Uncharacterized protein 
OS=Stenotrophomonas phage vB_SmaS-DLP_6 
1.53E-06 
gp106 hypothetical protein 51877 52128 + 80     
gp107 hypothetical protein 52113 52418 + 98     
gp108 hypothetical protein 52410 52819 + 133 A0A218M324_9VIRU Uncharacterized protein 
OS=Acidovorax phage ACP17 
2.85E-35 
gp109 hypothetical protein 52811 53083 + 85     
gp110 hypothetical protein 53064 53259 + 60     
gp111 hypothetical protein 53243 53534 + 93     
gp112 hypothetical protein 53521 53923 + 131     
gp113 hypothetical protein 53907 54135 + 72     
gp114 hypothetical protein 54107 54322 + 66     
gp115 hypothetical protein 54307 54509 + 62     
gp116 hypothetical protein 54552 54976 + 137     
gp117 hypothetical protein 54975 55163 + 59     
gp118 hypothetical protein 55150 55525 + 121 A0A142F003_9VIRU Uncharacterized protein 
OS=Stenotrophomonas phage vB_SmaS-DLP_6 
6.70E-13 
gp119 hypothetical protein 55512 55716 + 65     
gp120 hypothetical protein 55698 56255 + 181 A0A0H4INI0_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage IME-SM1 
2.73E-05 
gp121 hypothetical protein 56245 56547 + 97     
gp122 FAD-dependent 
thymidylate synthase 
56548 57530 + 324 A0A142EZP7_9VIRU FAD-dependent 
thymidylate synthase OS=Stenotrophomonas 
phage vB_SmaS-DLP_6 , IPR003669 
1.07E-146 
gp123 hypothetical protein 57507 57798 + 94     
gp124 hypothetical protein 57782 57992 + 66 A0A142EZP7_9VIRU FAD-dependent 
thymidylate synthase OS=Stenotrophomonas 





Table 8. Continued 
GP Name Start End  Strand Length (AA)  Representative homologue  E value  
gp125 hypothetical protein 57968 58323 + 114     
gp126 hypothetical protein 58307 58721 + 134     
gp127 hypothetical protein 58706 59014 + 99     
gp128 hypothetical protein 59003 59289 + 92 IPR025109 3.60E-30 
gp129 hypothetical protein 59273 59558 + 91 A0A1B2IGA5_9CAUD Uncharacterized protein 
OS=Erwinia phage vB_EamM_Phobos  
1.46E-06 
gp130 hypothetical protein 59529 59773 + 77     
gp131 6-pyruvoyl 
tetrahydropterin synthase 
59789 60308 + 169 IPR007115 2.20E-14 
gp132 hypothetical protein 60313 61040 + 239     
gp133 hypothetical protein 61143 61616 + 154     
gp134 hypothetical protein 61650 61877 + 72     
gp135 hypothetical protein 61863 62224 + 116     
gp136 hypothetical protein 62227 62717 + 160 E5E470_9CAUD Uncharacterized protein 
OS=Acinetobacter phage Acj6 
1.40E-14 
gp137 hypothetical protein 62803 63047 + 76     
gp138 hypothetical protein 63040 63412 + 121     
gp139 RNA ligase 63411 64588 + 389 IPR021122 2.90E-15 
gp140 hypothetical protein 64574 64953 + 123 B2ZXP5_9CAUD Uncharacterized protein 
OS=Ralstonia phage phiRSL1 
9.36E-08 
gp141 YbiA-like protein 64934 65408 + 153 IPR012816 5.40E-24 
gp142 hypothetical protein 65386 65760 + 121     
gp143 hypothetical protein 65746 65948 + 64     
gp144 hypothetical protein 65965 66171 + 65 W8EDH1_9CAUD Uncharacterized protein 
OS=Pseudomonas phage phiPsa374 
1.81E-05 
gp145 hypothetical protein 66160 66395 + 75     
gp146 hypothetical protein 66565 66779 + 67     
gp147 hypothetical protein 67074 67671 + 196     
gp148 hypothetical protein 67662 68313 + 213     




Table 8. Continued  
GP Name Start End  Strand Length (AA)  Representative homologue  E value  
gp150 tail fiber protein 68978 70724 + 579 A0A031IUV4_9PSED Phage-related tail fiber 
protein-like protein OS=Pseudomonas sp. 
RIT357 
2.48E-21 
gp151 tail fiber protein 70800 74954 + 1381 A0A142EZL1_9VIRU Tail fiber protein 
OS=Stenotrophomonas phage vB_SmaS-DLP_6 
2.35E-167 
gp152 hypothetical protein 74938 75352 + 134 A0A142EZY6_9VIRU Uncharacterized protein 
OS=Stenotrophomonas phage vB_SmaS-DLP_6 
1.13E-47 
gp153 hypothetical protein 75342 75840 + 163     
gp154 hypothetical protein 75877 76273 + 128     
gp155 hypothetical protein 76267 76521 + 82     
gp156 endolysin A 76506 77165 + 214 ENLYS_BPMD2 Endolysin A 
OS=Mycobacterium phage D29  
6.18E-09 
gp157 hypothetical protein 77157 77483 + 105     
gp158 Cell wall hydrolase 77599 78208 + 199 IPR011105 2.70E-26 
gp159 hypothetical protein 78238 78449 + 67     
gp160 RNA ligase A 78467 79595 + 372 NP_049839.1 T4_gene_rnlA RNA ligase A, 
IPR019039 
3.96E-24 
gp161 hypothetical protein 79583 79792 + 66     
gp162 hypothetical protein 79997 80223 + 71 A0A0E3JI93_9CAUD Uncharacterized protein 
OS=Rhodoferax phage P26218 
3.20E-13 
gp163 hypothetical protein 80222 80544 + 103     
gp164 hypothetical protein 80531 80669 + 42     
gp165 hypothetical protein 80662 80817 + 48     
gp166 hypothetical protein 80801 81074 + 87     
gp167 hypothetical protein 81058 81310 + 80     
gp168 hypothetical protein 81278 81677 + 129     
gp169 hypothetical protein 81661 81826 + 51     
gp170 hypothetical protein 81812 82143 + 106     
gp171 hypothetical protein 82225 82549 + 104     
gp172 hypothetical protein 82657 83045 + 125     




Table 8. Continued 
GP Name Start End  Strand Length (AA)  Representative homologue  E value  
gp174 hypothetical protein 83440 83647 + 66     
gp175 hypothetical protein 83634 83928 + 95     
gp176 tRNA nucleotidyl 
transferase 
83912 84998 + 357 A0A292GDU1_9VIRU CCA tRNA nucleotidyl 
transferase OS=Xanthomonas phage XacN1 
3.42E-116 
gp177 hypothetical protein 84978 85365 + 125     
gp178 hypothetical protein 86106 86335 + 72     
gp179 hypothetical protein 86380 87028 - 213 A0A218M3F0_9VIRU Uncharacterized protein 
OS=Acidovorax phage ACP1 
4.24E-55 
gp180 DNA end protector 
protein 
87015 87633 - 202 NP_049754.1 T4_gene_2 DNA end protector 
protein 
1.29E-16 
gp181 head completion protein 87624 88093 - 152 NP_049755.1 T4_gene_4 head completion 
protein 
6.57E-34 
gp182 hypothetical protein 88150 88284 - 39     
gp183 baseplate tail tube cap 88356 89081 + 237 A0A0H4ISA7_9CAUD Putative tail tube 
associated base plate protein 
OS=Stenotrophomonas phage IME-SM1 
7.84E-69 
gp184 baseplate wedge subunit 89068 89622 + 180 NP_049756.1 T4_gene_53 baseplate wedge 
subunit, IPR022607 
3.39E-06 
gp185 hypothetical protein 89609 90848 + 410 A0A0H4J2I9_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage IME-SM1  
1.39E-157 
gp186 baseplate central spike 
complex protein 
90909 92313 + 465 NP_049757.1 T4_gene_5 baseplate hub subunit 
and tail lysozyme, IPR009590 
3.08E-22 
gp187 hypothetical protein 92478 92924 + 144 A0A223AIZ9_9VIRU Uncharacterized protein 
OS=Acidovorax phage ACP17 
3.95E-61 
gp188 hypothetical protein 92983 93415 - 140     
gp189 hypothetical protein 93413 93896 - 157 IPR025358 5.40E-24 
gp190 hypothetical protein 93925 94342 - 135     
gp191 hypothetical protein 94319 94569 - 79     
gp192 hypothetical protein 94694 94951 - 82 A0A0H4ISC1_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage IME-SM1 
6.17E-04 
gp193 hypothetical protein 95056 95289 - 74     




Table 8. Continued  
GP Name Start End  Strand Length (AA)  Representative homologue  E value  
gp195 hypothetical protein 95479 96297 - 269 A0A292GL82_9VIRU DUF4343 domain 
containing protein OS=Xanthomonas phage 
XacN1, IPR025643 
2.90E-110 
gp196 flotillin-like protein 96354 97734 - 455  A0A1H0ZF08_9GAMM Flotillin 
OS=Pseudoxanthomonas sp. CF125 , 
IPR027705 
8.57E-169 
gp197 hypothetical protein 97718 98297 - 190 Q7Y4Z4_BPR69 Uncharacterized protein  
OS=Enterobacteria phage RB69 
3.69E-04 
gp198 hypothetical protein 98287 98583 - 94     
gp199 hypothetical protein 98565 98983 - 136     
gp200 hypothetical protein 98972 99393 - 137 A0A024AZ34_9CAUD Uncharacterized protein 
OS=Bacillus phage CAM003  
1.18E-20 
gp201 hypothetical protein 99392 99788 - 129     
gp202 hypothetical protein 99765 100011 - 77     
gp203 hypothetical protein 100013 100220 - 69     
gp204 hypothetical protein 100224 100456 - 74     
gp205 hypothetical protein 100442 100676 - 74     
gp206 hypothetical protein 100660 101013 - 112     
gp207 hypothetical protein 101051 102898 + 612 A0A0H4ISB2_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage IME-SM1 
8.65E-168 
gp208 hypothetical protein 102883 103827 + 310 A0A239NNH2_9GAMM Uncharacterized 
protein OS=Stenotrophomonas sp. YR34 
1.06E-24 
gp209 hypothetical protein 103822 104813 + 325     
gp210 hypothetical protein 104828 105248 + 136     
gp211 hypothetical protein 105290 106528 + 408     
gp212 concanavalin A-like 
lectin/glucanase domain 
superfamily 
106518 108927 + 800 IPR013320 3.82E-22 
gp213 hypothetical protein 109008 112214 + 1065 A0A218M2T2_9VIRU Uncharacterized protein 
OS=Acidovorax phage ACP17 
4.17E-51 
gp214 hypothetical protein 112433 113539 + 365 A0A0H4ISB7_9CAUD Uncharacterized protein 





Table 8. Continued 
GP Name Start End  Strand Length (AA)  Representative homologue  E value  
gp215 hypothetical protein 113747 114049 + 95 NP_049763.1 T4_gene_5.4 gp5.4 conserved 
hypothetical protein, IPR008727 
1.73E-05 
gp216 baseplate wedge subunit 114107 114438 + 107 IPR007048 3.10E-06 
gp217 baseplate wedge subunit 114423 116204 + 590 NP_049764.1 T4_gene_6 baseplate wedge 
subunit 
7.55E-30 
gp218 hypothetical protein 116187 117697 + 499 A0A0H4ITL7_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage IME-SM1 
2.15E-171 
gp219 baseplate wedge subunit 117695 119232 + 508 IPR015298 7.32E-16 
gp220 hypothetical protein 119231 122489 + 1083 IPR032096 1.50E-16 
gp221 hypothetical protein 122494 125035 + 844 A0A1S5R3Y8_9VIRU Uncharacterized protein 
OS=Pseudomonas phage pf16  
5.70E-28 
gp222 hypothetical protein 125076 125235 + 50     
gp223 neck protein 125367 126141 + 255 NP_049772.1 T4_gene_13 neck protein 2.82E-22 
gp224 neck protein 126163 126819 + 215 NP_049773.1 T4_gene_14 neck protein, 
IPR021674 
5.24E-17 
gp225 tail sheath stabilizer and 
completion protein 
126807 127559 + 247 NP_049774.1 T4_gene_15 tail sheath stabilizer 
and completion protein, IPR031997 
2.01E-17 
gp226 hypothetical protein 127550 127841 + 93     
gp227 small terminase subunit 127829 128350 + 170 NP_049775.1 T4_gene_16 small terminase 
protein, IPR020342 
1.67E-07 
gp228 large terminase subunit 128839 130498 + 550 NP_049777.1 T4_gene_17 large terminase 
protein, IPR004921 
2.04E-118 
gp229 tail sheath protein 130555 132544 + 659 NP_049780.1 T4_gene_18 tail sheath protein, 
IPR007067 
8.64E-80 
gp230 hypothetical protein 132620 133081 + 150     
gp231 tail tube protein 133145 133706 + 183 NP_049781.1 T4_gene_19 tail tube protein, 
IPR010667 
1.70E-20 
gp232 portal protein 133778 135456 + 556 NP_049782.1 T4_gene_20 portal vertex protein, 
IPR010823 
1.93E-98 
gp233 putative prohead core 
protein 
135443 136250 + 265 A1XGY5_9CAUD GP68-prohead core protein 





Table 8. Continued  
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gp234 hypothetical protein 136235 136495 + 82     
gp235 prohead core scaffolding 
protein protease 
136500 137203 + 230 NP_049785.1 T4_gene_21 prohead core 
scaffolding protein and protease , IPR005082 
1.17E-18 
gp236 prohead core protein 137257 138078 + 270 NP_049786.1 T4_gene_22 prohead core protein 1.27E-05 
gp237 major capsid protein 138135 139384 + 412 NP_049787.1 T4_gene_23 major capsid protein, 
IPR010762 
1.49E-77 
gp238 hypothetical protein 139745 140029 + 91     
gp239 deoxynucleoside 
monophosphate kinase 
140016 140571 + 182 NP_049752.1 T4_gene_1 deoxynucleoside 
monophosphate kinase 
2.28E-18 
gp240 tail completion and 
sheath stabilizer protein 
140579 141062 + 161 NP_049753.1 T4_gene_3 tail completion and 
sheath stabilizer protein 
2.88E-13 
gp241 UvsY recombination, 
repair and ssDNA 
binding protein 
141035 141474 + 142 NP_049799.2 T4_gene_uvsY UvsY 
recombination, repair and ssDNA binding 
protein , IPR021289 
1.08E-07 
gp242 homing endonuclease 141501 142066 + 185 A0A0B5H2A1_9CAUD Homing endonuclease 
OS=Salmonella phage Mushroom 
1.78E-06 
gp243 UvsW helicase 142059 143568 + 500 NP_049796.1 T4_gene_uvsW UvsW helicase 1.52E-91 
gp244 hypothetical protein 143519 143987 + 153     
gp245 RNA polymerase sigma 
factor 
144003 144483 + 160 NP_049679.1 T4_gene_55 RNA polymerase 
sigma factor 
1.26E-13 
gp246 endonuclease subunit 144481 145554 + 354 NP_049672.1 T4_gene_47 endonuclease subunit  6.44E-38 
gp247 hypothetical protein 145541 145772 + 74     
gp248 recombination 
endonuclease subunit 
145756 147487 + 573 NP_049669.1 T4_gene_46 endonuclease 
subunit, IPR003395 
1.03E-84 
gp249 hypothetical protein 147466 147711 + 76     
gp250 hypothetical protein 147706 147882 + 55     
gp251 sliding clamp 147948 148601 + 213 NP_049666.1 T4_gene_45 sliding clamp 1.25E-18 
gp252 hypothetical protein 148589 149022 + 140     
gp253 clamp loader small 
subunit 
149035 149992 + 315 NP_049665.1 T4_gene_44 clamp loader, small 
subunit  
1.21E-45 
gp254 clamp loader A subunit 149998 150414 + 135 NP_049664.1 T4_gene_62 clamp loader small 





Table 8. Continued 
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gp255 translation repressor 
RegA 
150371 150808 + 142 NP_049663.1 T4_gene_regA translation 




150781 151448 + 218 IPR008180 2.40E-19 
gp257 hypothetical protein 151437 151735 + 96 A0A0H4ITP8_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage IME-SM1 
2.70E-13 
gp258 hypothetical protein 151806 151943 + 42     
gp259 DNA polymerase 152076 154772 + 894 NP_049662.1 T4_gene_43 DNA polymerase, 
IPR006134 
5.72E-113 
gp260 hypothetical protein 154772 155143 + 120     
gp261 UvsX RecA-like 
recombination protein 
155127 156195 + 352 NP_049656.2 T4_gene_uvsX UvsX RecA-like 
recombination protein, IPR013765 
3.17E-121 
gp262 hypothetical protein 156179 157160 + 322 A0A0H4ITQ9_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage IME-SM1 
8.61E-14 
gp263 hypothetical protein 157145 157435 + 92     




158145 158694 + 180 IPR002500 1.90E-05 
gp266 hypothetical protein 158701 159349 + 216     
gp267 hypothetical protein 159325 159773 + 144     
gp268 glycosyl transferase 159755 160927 + 386 IPR001296 6.10E-12 
gp269 hypothetical protein 160920 162242 + 438 A0A218M2Y9_9VIRU Uncharacterized protein 
OS=Acidovorax phage ACP17 
9.92E-47 
gp270 hypothetical protein 162298 162684 + 124     
gp271 queuosine biosynthesis 
QueE radical SAM 
162669 163577 + 298 A0A0H4ITQ6_9CAUD Queuosine biosynthesis 
QueE radical SAM OS=Stenotrophomonas 
phage IME-SM1 
2.64E-134 
gp272 hypothetical protein 163660 163882 + 70     
gp273 hypothetical protein 163864 164073 + 65     




Table 8. Continued 
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gp275 hypothetical protein 164209 164659 + 146 A0A2D1GNA1_9VIRU Uncharacterized 
protein OS=Pseudoalteromonas phage J2-1 
7.36E-23 
gp276 ATP-dependent DNA 
helicase 
164645 166059 + 468 NP_049654.1 T4_gene_41 41 helicase  6.73E-107 
gp277 hypothetical protein 166043 166307 + 83     
gp278 hypothetical protein 166556 167585 - 340 NP_049708.1 T4_gene_nrdC.10 NrdC.10 
conserved hypothetical protein 
1.27E-70 
gp279 hypothetical protein 167682 168758 + 356 A0A0H4J2Q0_9CAUD Uncharacterized protein 
OS=Stenotrophomonas phage IME-SM1  
4.03E-12 
gp280 hypothetical protein 168746 169759 + 334     
gp281 hypothetical protein 169746 170616 + 287     
gp282 phosphopantetheine 
adenylyltransferase 
170598 171097 + 163 COAD_PROA2 Phosphopantetheine 
adenylyltransferase OS=Prosthecochloris 
aestuarii (strain DSM 271 / SK 413) 
8.64E-09 
gp283 hypothetical protein 171078 171320 + 77     
gp284 hypothetical protein 171313 172212 + 297     
gp285 hypothetical protein 172190 172621 + 139 A0A218M349_9VIRU Uncharacterized protein 
OS=Acidovorax phage ACP17 
2.96E-41 
gp286 baseplate hub subunit 172615 173409 + 261 NP_049801.1 T4_gene_26 gp26 baseplate hub 
subunit  
2.02E-04 
gp287 hypothetical protein 173569 175809 + 744 IPR023346 8.44E-14 
gp288 i-spanin 175801 176379 - 189     
gp289 o-spanin 175860 176157 - 90     
gp290 hypothetical protein 176367 176758 - 127 A0A218M2Z8_9VIRU Uncharacterized protein 
OS=Acidovorax phage ACP17 
5.11E-18 
gp291 hypothetical protein 176757 177264 - 165     
gp292 DNA primase 177365 178334 + 318 NP_049648.1 T4_gene_61 DNA primase 6.72E-43 
gp293 PhoH-like protein 178324 179044 + 237 IPR003714 9.50E-41 
gp294 hypothetical protein 179042 179256 + 68     
gp295 hypothetical protein 179245 179442 + 61     




Table 8. Continued  
GP Name Start End  Strand Length (AA)  Representative homologue  E value  
gp297 putative regulatory 
protein, FmdB 
180292 180564 + 85 IPR013429 1.30E-09 
gp298 hypothetical protein 180553 180839 + 92     
gp299 restriction endonuclease 
type II-like 
180818 181491 + 220 IPR015085 9.92E-06 
gp300 hypothetical protein 181473 181733 + 82     
gp301 hypothetical protein 181720 181954 + 75     
gp302 T4-like gp59 loader of 
DNA helicase 
182020 182547 + 172 NP_049856.1 T4_gene_59 59 protein, 
IPR015085 
5.14E-08 
gp303 single-stranded DNA 
binding protein 
182587 183510 + 304 NP_049854.1 T4_gene_32 single-stranded DNA 




183707 187765 + 1347 IPR012317 5.90E-08 
gp305 exoribonuclease 187829 188474 + 212 NP_049629.1 T4_gene_dexA exonuclease, 
IPR033390 
2.55E-29 
gp306 hypothetical protein 188463 188876 + 134 A0A142EZY4_9VIRU Uncharacterized protein 
OS=Stenotrophomonas phage vB_SmaS-DLP_6   
5.52E-11 
gp307 hypothetical protein 188923 189169 + 78     
gp308 hypothetical protein 189164 189363 + 63     
gp309 hypothetical protein 189359 189599 + 80     
gp310 hypothetical protein 189574 189909 + 108     
gp311 hypothetical protein 189888 190072 + 57     
gp312 hypothetical protein 190050 190253 + 63     
gp313 hypothetical protein 190240 190615 + 121     
gp314 hypothetical protein 190591 190880 + 91     
gp315 hypothetical protein 190852 191154 + 97 A0A0H4INW9_9CAUD Uncharacterized 
protein OS=Stenotrophomonas phage IME-SM1 
5.43E-11 
gp316 hypothetical protein 191112 191326 + 68 A0A142F092_9VIRU Uncharacterized protein 
OS=Stenotrophomonas phage vB_SmaS-DLP_6   
2.67E-11 
gp317 hypothetical protein 191319 191457 + 43     




Table 8. Continued  
GP Name Start End  Strand Length (AA)  Representative homologue  E value  
gp319 hypothetical protein 192113 192298 + 58     
gp320 hypothetical protein 192346 192798 + 147     
gp321 hypothetical protein 192842 193121 + 93     
gp322 Cytidyltransferase-like 
protein 
193138 194268 + 373 IPR005123 1.00E-06 
gp323 oxoglutarate/iron-
dependent dioxygenase 
194239 194980 + 242 IPR005123 5.40E-10 
gp324 NAD/GMP synthase 194972 195815 + 277 IPR022310 2.30E-29 
gp325 hypothetical protein 195858 197010 + 381 A0A292GJP9_9VIRU Uncharacterized protein 
OS=Xanthomonas phage XacN1 
3.33E-119 
gp326 hypothetical protein 197034 197643 + 199 A0A191ZBT9_9CAUD Uncharacterized protein 




197723 198779 + 348 A0A142EZP1_9VIRU ADP-ribose 
pyrophosphatase OS=Stenotrophomonas phage 
vB_SmaS-DLP_6  
8.19E-127 
gp328 hypothetical protein 198777 199186 + 132     
a GP = Gene products 





CHAPTER III  
RECEPTOR SITE IDENTIFICATION 
 
Introduction 
Adsorption is a key step in the phage infection process. A phage cannot infect its 
host if the receptor becomes inaccessible or non-complementary to the phage receptor-
binding proteins (Bertozzi Silva et al., 2016). Receptor identification is very important 
because mutational receptor loss is one common cause of phage resistance (Levin and Bull, 
2004). My objective is to identify the receptor site(s) for the three characterized virulent 
phages of Xac. A comparison of the genome sequence of a phage-sensitive wild type strain 
to that of a phage resistant mutants can help to identify  the site of the mutation that 
confers resistance, and thus possibly the receptor. Another approach can be a rational 
selection of potential phage receptors. Since it is known that twitching motility, biofilm 
formation, adherence and infection by an uncharacterized phage of Xac are mediated by 
type IV pili (T4P) (Dunger et al., 2014), a deletion mutation in the major pilus subunit 
gene pilA is a rational  approach.  
Materials and methods  
Bacterial strains and plasmids conditions  
Bacterial strains and plasmids used in this study are listed in Table 9. Xac strains 
were cultured at 28ºC in MNBY broth or agar plates. For Xac cultures harboring plasmids, 
MNBY medium was supplemented with kanamycin (Km, 30 µg/ml). Yeast tryptone broth 
(YTB: 10 g/liter tryptone, 10 g/liter yeast extract) and yeast-tryptone agar amended with 




were used for resolution of mutants.  Escherichia coli strains were cultured at 37°C in LB 
broth or LB agar (Bertani, 1951). For E. coli cultures harboring plasmids, LB medium was 
supplemented with Km (30 µg/ml).  
 
Table 9. Bacterial strains and plasmids used in this study. 
Strain or plasmid Genotype and relevant featuresa Reference  
Xanthomonas 
    EC-12 Xanthomonas sp., rice isolate  
(ATCC PTA-13101) 
(Ahern et al., 
2014) 
    Block 22 X. axonopodis pv. citri, sweet orange 
isolate 
Wang, N.b 
    Block 22-ΔpilA Block 22, unmarked deletion of pilA This study 
    Block 22-Comp Block 22, pMo168::pilA This study 
E.  coli 
    E. cloni 5-alpha fhuA2Δ(argF-lacZ)U169 phoA glnV44 
Φ80Δ(lacZ)M15 gyrA96 recA1 relA1 
endA1 thi-1 hsdR17 
Lucigen 
Plasmids 
    pMo130 Suicide vector for allelic exchange; 
ColE1 ori, RK2 oriT, xylE, sacB, Kmr 
(Hamad et al., 
2009) 
    pMo130::pilA pM0130 with pilA upstream and 
downstream fragments 
This study 
    pMo168 Replicative vector; ori pBBR1, mob+, 
xylE, Kmr 
(Hamad et al., 
2009) 
    pMo168::pilA comp pilA clones into pMo168 This study 
a Kmr = resistance to kanamycin. 




Construction of Xac Block 22 pilA deletion and in-trans complementation 
The system developed by Hamad et al. (Hamad et al., 2009) with modifications 





Figure 9. Strategy for Type IV pili gene deletion and complementation of Xac (Figure 




 PCR primers for regions flanking pilA (XAC3241) were designed based on the 
annotated sequence of Xac 306 reference genome (Accession: GCA_000007165.1). All 
plasmid constructs used in this study were generated using E. coli E. cloni 5-alpha 
(Lucigen) as host. Plasmids pMo130 and pMo168 were used in this study. Plasmid 
pMo130, a suicide vector, carries a ColE1 origin of replication derived from pUC19 and 
can be used for allelic exchange to generate in-frame deletions in bacterial genome. 
Plasmid pMo168, a replicative vector, carries the PBBR1 origin of replication and can be 
used for in-trans complementation or gene expression in bacteria. Both plasmids carry an 
origin of transfer that aid their mobilization into the pathogen through conjugation. Both 




that turns a colorless catechol substrate (pyrocatechol) into a bright yellow-colored 2-
hydroxymuconic semialdehyde (Lee et al., 1996).  
In order to construct the plasmid pMo130::pilA used in the deletion of pilA from 
the Block 22 strain, one kb fragment upstream of the pilA was amplified using ΔpilA-US-F 
and ΔpilA-US-R primers set (Table 4), digested with NheI and BglII and cloned into 
multiple cloning sites (MSC) 1 of plasmid pMo130, to obtain pMo130::pilA-up. The one 
kb fragment downstream of pilA was amplified using ΔpilA-DS-F and ΔpilA-DS-R primers 
set (Table 4). The PCR product was digested with BglII and HindIII, then cloned into 
pMo130::pilA-up to generate pMo130::pilA. Plasmid pMo130::pilA was introduced into 
electro-competent cells of Block 22 by electroporation (White and Gonzalez, 1995). Cells 
were allowed to recover in MNBY broth at 28ºC for 5 h with constant shaking (120 rpm). 
After incubation, 50, 100, and 150 µl of cells were plated to MNBY Km plates (30 µg/ml). 
After 72 h, the resulting colonies were sprayed with 0.45 M pyrocatechol to identify 
colonies in which single crossover events had occurred. Single yellow colonies were 
grown in YTB for 9 h then spread onto YTSA plates for selection of resolved co-
integrants. The colonies that grew on YTSA were sprayed with 0.45 M pyrocatechol. To 
confirm pilA deletion, the presumptive resolved co-integrants exhibiting a white phenotype 
were analyzed by PCR using multiple primer combinations both internal and external to 
the target gene deletion and by sequencing of PCR product as well. The deletion mutants 
were also evaluated for phage activities.  
To complement the Block 22-ΔpilA mutant, the wild-type pilA gene was introduced 
using a derivative of the plasmid pMo168. The pilA gene containing its regulatory region 




set (Table 10). The PCR product was digested with PstI and XbaI, and then cloned into 
pMo168 MCS-2, resulting in pMo168::pilA. The pMo168::pilA plasmid was introduced 
into Block 22-ΔpilA by electroporation as described above and plated to MNBY Km plates 
(30 µg/ml) for selection. Transformants were sprayed with 0.45 M pyrocatechol to identify 
colonies that contained the pMo168 derivative plasmid. The presence of the wild-type pilA 
gene was confirmed in transformants by PCR amplification and sequencing of PCR 
product. The complements were evaluated for restoration of phage sensitivity.  
 
Table 10. Primers used in Chapter III for cloning experiments. 
Primer Sequencea Reference 
ΔpilA-US-F 5'-GAGAGCTAGCGATTGCACTGACCAACATCG-3' This study 
ΔpilA-US-R 5'-GAGAGATCTACCCTGTTGCTTCTTCATGG-3' This study 
ΔpilA-DS-F 5'-CTCTAGATCTTGCCAGTAATATTTGAACGTTTC-3' This study 
ΔpilA-DS-R 5'-CTCTAAGCTTGATTGCTCACCCCTACGAAC-3' This study 
pilA-comp-F 5'-GAGCTGCAGGGGATATCCATGAAGAAGCA-3' This study 
pilA-comp-R 5'-GAGTCTAGAGGAAGCAAGCACCGCGATTA-3' This study 
pilA-U-F 5'-GATCGCAGTTCTTGTGTTTGCCTC-3' This study 
pilA-M-R 5'-CCAACACCGTAATCGCAGAAC-3' This study 
pilA-M-F 5'-GTTCTGCGATTACGGTGTTGG-3' This study 
pilA-M-R 5'-GGAAGCAAGCACCGCGATTA-3' This study 




Isolation and characterization of phage resistant mutants 
 Xac isolates were exposed to high titer phage lysates for isolation of resistant 
mutants. Using the soft agar overlay protocol described previously, host and phage were 
mixed at a MOI of 10 and poured onto MNBY plates. Plates were assessed daily for the 
development of phage resistant colonies. Colonies were streak purified a minimum of 3 




resistance by exposure to a phage dilution series. Randomly selected mutants were 
sequenced and compared with the wild type to determine what mutations in the 
chromosome were associated with phage resistance.  
Bacterial genomic DNA extraction 
 ZR Fungal/Bacterial DNA MiniPrep Kit (Cat. No: D6005), Zymo Research, was 
used to extract bacterial genomic DNA. Briefly, bacterial cells from an overnight MNBY 
agar plate (~50-100 mg) were resuspended in 200 µl of distilled water and then added to 
ZR BashingBead Lysis Tube along with 750 µl of BashingBead buffer solution. The tubes 
were placed in the bead beater (Disruptor Genie), processed for 20 min and centrifuged at 
10,000 x g at 25ºC for 1 min. Four hundred microliters of supernatant were transferred to a 
Zymo-Spin IV Spin Filter in a collection tube and centrifuged at 8,000 x g for 1 min at 
25ºC. DNA extraction was completed by following the protocol according to the 
manufacturer and the DNA was stored at -20 ºC. 
Bacterial whole genome sequencing and analysis 
 Bacterial DNA was sequenced using the Illumina MiSeq platform to generate 
paired-end 250 bp reads according to the manufacturer’s guidelines. FastQC 
(bioinformatics.babraham.ac.uk), FastX Toolkit (hannonlab.cshl.edu), and SPAdes 3.5.0 
(Bankevich et al., 2012) were used for read quality control, read trimming, and read 
assembly, respectively. The wild type and mutant genomes were assembled into contigs 
and then mapped to a close reference sequence Xac strain 306 (Accession: 
GCA_000007165.1). The tool BWA-MEM was used to map each bacterial strain’s set of 
trimmed reads, both forwards and reverse, to the reference genome (Li, 2013; Li and 




Integrative genomics viewers (IGV) for further analysis (Robinson et al., 2011; 
Thorvaldsdóttir et al., 2013). In order to assess if the mutation that resulted in phage 
resistance was caused by a single nucleotide polymorphism (SNP) or an INDEL, we took 
the previously generated BWA files and applied the tool VarScan2 Call SNPs, Varscan2 
Call INDELs (Koboldt et al., 2012). These tools were run on the default settings, which 
resulted in a number of calls that were of dubious quality. In order to remove the lower 
quality calls, we filtered the results using a Filter tool (VarScan) available in Galaxy. 
VarScan gave a binary value to each of the calls it provided for a number of parameters. 
One of these parameters was homozygosity. We found that at the default value of 0.75, in 
the parameter, “VarScan: Minimum frequency to call homozygote” generated a binary 
indication of a quality dataset. Therefore, we sorted the generated INDEL and SNP data 
based on their homozygous score, with 2s being quality (homozygous) and 0s (non-
homozygous) being not quality. Using this filter made the output manually manageable. 
We manually analyzed the INDELs and SNPs to confirm in which gene the mutation had 
occurred and whether the associated changes resulted in a silent, nonsense, or missense 
mutation. Additionally, since this was a computationally annotated reference genome, we 
used NCBI BLAST and InterProScan to compare the gene homology if the reference 
genome had an undescriptive gene name (Altschul et al., 1990; Camacho et al., 2009; 
Jones et al., 2014).  
Microtiter assay for growth study  
A single colony in overnight broth culture of wild type and mutants were diluted and 
adjusted to OD600 = 1.0 (~ 10
9 CFU/ml) spectrophotometrically with MNBY broth, then 




351172). For each well, 180 µl of MNYB broth was added along with 20 µl of Xac wild 
type strain and the putative resistant mutants (~ 108 CFU/ ml final concertation). The plate 
was incubated at 28 ºC with double orbital shaking at 150 rpm in a Tecan Spark 10 M plate 
reader (Tecan Group Ltd., Männedorf, Switzerland). The growth was monitored at OD600 
at 30 min intervals for 23 h. After baseline adjustment, growth curves were generated by 
plotting OD600 measurements against time. All assays were done in triplicate.    
Results and discussion  
Deletion and complementation of pilA   
A requirement of T4P has been observed for the infection of several members from 
the Xanthomonadaceae family including Xanthomonas and  Xylella fastidiosa and 
members of the genus Pseudomonas (Ahern et al., 2014; Chibeu et al., 2009). Extensive 
research by several groups has been done to gain insights into the role played by T4P in 
bacteria-host interactions and pathogenesis, biofilm formation, twitching and sliding 
motility, and interactions with phages (Dunger et al., 2014; 2016). The T4P secretion 
machinery is made up of four subcomplexes: (i) the outer membrane subcomplex formed 
by the dodecameric ring of PilQ and the pilotin PilF, (ii) the inner membrane platform, 
made up of PilC, PilM, PilN, PilO and PilP, (iii) the ATPases PilB, PilT and PilU, and (iv) 
the pilus filament, a polymer of the major pilin, PilA, and minor pilins (Figure 10) (Dunger 






Figure 10. Type IV pilus machinery is made up of four subcomplexes: (i) the outer 
membrane subcomplex formed by the dodecameric ring of PilQ and the pilotin PilF, (ii) 
the inner membrane platform, made up of PilC, PilM, PilN, PilO and PilP, (iii) the 
ATPases PilB, PilT and PilU, and (iv) the pilus filament, a polymer of the major pilin, 




 Xac strain 306 (the reference genome in this studied) was sequenced and fully 
annotated. Its genome contains genes with all necessary components for a functional T4P 
(da Silva et al., 2002). Figure 11 shows the T4P genes cluster. 
 
 






 We chose to delete pilAXAC3241 in this study. As shown in Figure 11, the pilA genes 
(pilAXAC3240 and pilAXAC3241) are clustered with the other T4P-related genes pilS, pilR, pilB, 
pilC, and pilD. Previous studies showed while these two genes shared 67.6% amino acid 
sequences identity pilAXAC3241 was more conserved among the Xanthomonadaceae family 
compared with its adjacent downstream homolog (Dunger et al., 2014; Dunger et al., 
2016). Dunger at al. (2014) also showed that pilAXAC3241 was expressed at a significantly 
greater level than pilAXAC3240 and XAC3805 (minor pilin) in liquid culture and at all time 
points after infiltration into host plants.  
An in-frame deletion of pilA mutant was generated and complemented in-trans to 
examine the effect of the pilA mutation on plaque production. It was observed that Block 
22 was sensitive to all the selected phages, whereas Block 22-ΔpilA was insensitive to all 
three phages CCP504, CCP513, and CCP509. However, sensitivity to the selected phages 
was restored when the pilA protein was restored in-trans (Table 11).  
 
Table 11. Phage sensitivity testing of Block 22, ΔpilA mutant and complement.  
Phage ID (morphology) Block 22 Block 22-ΔpilA Block 22-Comp 
CCP504 (Podo) +a - + 
CCP513 (Sipho) + - + 
CCP509 (Myo) + - + 




Phage resistant mutant analysis by whole genome comparisons 
Spontaneous phage resistance mutants also were selected to determine if other 
mutations could confer phage resistance, and thus identify other possible receptor(s). Four 




with Block 22 (parental strain). Since Xac strain Block 22 was not sequenced previously, 
we used the fully annotated Xac 306 genome (Accession: GCA_000007165.1) as 
reference.  
Our analysis found 14 INDELs and 268 SNPs among the four resistant mutants that 
were sequenced. After manually evaluation, it was determined that mutations occurred in 
both coding and non-coding regions. The INDELs were found mostly in the non-coding 
region, with the exception of one each in dipeptidyl anminopeptidase (XAC0262), 
cointegrate resolution protein T, orfT, (XAC3229) and pilR (XAC3238). The SNPs were 
found in hypothetical proteins such as XAC0123, XAC1346, XAC2251, and XAC3502. 
SNPs were also identified in functional genes such as the outer membrane component of a 
multidrug efflux pump (XAC1526), chemotaxis protein (XAC 1896), succinate 
dehydrogenase flavoprotein subunit (XAC2077), htpG heat shock protein G (XAC2528),  
Acyl-CoA dehydrogenase (XAC3054), pilT (XAC2924), pilB (XAC3239) and orfT and 
orfS (XAC3227).  A SNP was identified in gene encoding for the outer membrane 
component of a multidrug efflux pump (XAC1526). However, the mutation in XAC1526 
was determined to be a silent, because the SNP from T to G at 1761903 kb did not result in 
a change to the amino acid sequence of the protein. The SNP in pilT (mutant RC3) that 
replaced a G with T resulted in a missense mutation due to a one amino acid substitution 
(Gly to Val). In addition, a missense mutation was located in pilB (mutant RC4) that was 
due to a SNP from G to A resulted in the substitution of Asp to Glu.  A frameshift 
mutation in pilR occurred due to a single base deletion.  Thus, the pilT and pilB SNPs and 
the pilR INDEL were identified as mutation in the T4P gene cluster that would potentially 








Mutant strain Position Change Mutation 
XAC2924 - pilT RC3 3431317 T SNP from G to T  
(Gly to Val) 
XAC3238 - pilR  RC4 3815895 +C Single base insertion  
XAC3239 - pilB RC1, RC4, 
RC11 
3818916 A SNP from G to A  




 The mutations were identified as possible receptor mutations because the mutations 
were localized in the T4P genes cluster (Figure 10 and 11). The pilR, pilT and pilB have 
important roles in T4P secretion machinery (Dunger et al., 2016). PilR is the response 
regulator in the two component system that controls transcription of the major pilin gene 
pilA (Hobbs et al., 1993). The binding of phosphorylated pilR to sequences upstream of the 
pilA promotor activates the transcription of pilA and results in the expression of pilin 
(Yang et al., 2004). Therefore, a mutation in pilR can lead to the down-regulation of pilA, 
which can lead to abolishment of phage infection of Xac. PilB utilizes the energy of ATP 
hydrolysis to catalyze the pilin subunits during pilus extension/polymerization, whereas 
pilT catalyzes the removal of pilus subunits during retraction/polymerization (Dunger et 
al., 2016). A mutation in pilB can result in resistance to a pilus-specific phage, as observed 
for phage PO4 (Nunn et al., 1990; Turner et al., 1993). A knockout of pilB abolishes T4P 
synthesis resulting in phage resistance. It also affects twitching motility and plant 
adherence in Xanthomas spp. (Dunger et al., 2014; Guzzo et al., 2009). Previous studies 
showed that pilT mutants are hyperpiliated but are deficient in pilus retraction (Bertrand et 
al., 2010; Graupner et al., 2001; Okamoto and Ohmori, 2002; Whitchurch and Mattick, 




One of the challenges of phage therapy is the emergence of phage resistant mutants. 
However, in the case where T4P is the primary receptor, a mutation in an associated gene 
that results in impaired or no pilus function can have multiple effects on the bacterial host. 
Lack of pilus function can affect the fitness of the bacterium because of the role of function 
T4P in surface attachment, biofilm formation, and cell-to-cell aggregation (Dunger et al., 
2014; Su et al., 1999; Yang et al., 2004). In in vitro studies, it was observed that phage 
resistant mutants exhibited reduced growth as compared to the wild type strain (Figure 12) 
indicating the loss of fitness associated with phage resistance.   
 In future studies, we would like to complement the pilT, pilB and pilR mutants to 
test their ability to restore phage sensitivity, and we would also like to test the 
pathogenicity of these mutants on host plants to further understand the fitness costs 






Figure 12. Growth defects associated with phage resistant mutants. The experiments were 


























CHAPTER IV  
EFFICACY STUDIES OF PHAGES COCKTAIL TO REDUCE CANKER SYMPTOMS 
IN GREENHOUSE TRIALS 
 
Introduction  
A biocontrol agent(s) can be used to prevent (prophylactic treatment) or treat 
(therapeutic treatment) disease. For prophylactic treatment, the phage cocktail is applied 
prior to the arrival of the pathogen. For therapeutic treatment, the phage cocktail would be 
introduced soon after the infection process has occurred, with the purpose of  reducing the 
population in infected tissue to reduce disease severity (Svircev et al., 2018). Prevention is 
generally a better approach than treatment of the disease, but it is not always cost-efficient 
or possible. Citrus canker is primarily spread by wind and rain, therefore reducing the 
inoculum load is important in preventing disease spread. The efficacy of both options was 
evaluated as part of this biocontrol development. Since Xac naturally enters the leaf via 
stomatal openings, and then colonizes the apoplast, the phage and bacteria were sprayed 
specifically onto the leaves in greenhouse studies. All greenhouse experiments were 
conducted in cooperation with Dr. Nian Wang (Citrus Research and Education Center in 
Lake Alfred, FL). In Chapters II and III, I presented data on the isolation and 
characterization of Xac phages, with focus on phages CCP504, CCP509 and CCP513. 
Since the efficacy studies were conducted before full characterization of the phages could 
be completed, four phages were chosen for the greenhouse studies based on morphology, 




cocktail, in efficacy studies were three KMV-like podophages (CCP504, CCP505 and 
CCP511) and one siphophage (CCP513).   
Materials and methods 
Bacterial strain and phages 
The canker bacterium Xac used in this study was stored at −80º C in nutrient broth 
(NB) (BBL, Becton Dickinson and Co., Cockeysville, MD) with 25% glycerol. For all 
experiments, the bacterial strain was grown on nutrient agar (NA) medium (BBL, Becton 
Dickinson and Co.) at 28º C. For preparation of bacterial suspensions, 36 h cultures were 
suspended in sterile tap water (STW), the concentration adjusted to 5× 108 CFU/ml, and 
diluted appropriately. Bacteriophages used in this study were stored at 4°C in the dark. The 
phage cocktail used in plant trials was composed of three KMV-like podophages (CCP504, 
CCP505 and CCP511) and one siphophage (CCP513).  The cocktail was an equal mixture 
of each of the phages with a final titer of 1 x 1010 PFU/ml and was diluted to desired 
concentrations in STW for greenhouse trials. 
Plant greenhouse assays  
Twenty week old Hamlin sweet orange plants were grown in 25-cm plastic pots in 
Fafard Professional Potting Mix (Sun Gro Horticulture, Agawam, MA) in a citrus canker 
quarantine greenhouse at 25 to 30°C in Lake Alfred, FL. The plants were watered every 
other day with tap water and fertilized with Peter professional ® 20-10-20 general purpose 
fertilizer (ICL Specialty Fertilizers, Dublin, Ohio) every seven days. The greenhouse 
(plastic roof, partially clear but not completely clear) received natural sunlight and no 
artificial light during the assays. The plants were heavily trimmed and fertilized to induce a 




inoculation. The inoculation was performed by a spray method with a hand-held 200 ml 
plastic spray bottle. The bottle was sterilized with 70% ethanol and washed with sterile tap 
water before use. Briefly, the abaxial surfaces of fully expanded, immature leaves of each 
plant were sprayed with a 20 ml aliquot of the following treatments: Xac only (disease 
control), phage cocktail only (phage control), phage (pre-phage treatment) followed by Xac 
6 h later, or Xac inoculated 6 h prior to phage treatment (post-Xac treatment). Sterile tap 
water was used as a non-treament control. Xac strain Block 22 was used for inoculation of 
plants. Block 22 was grown on NA medium at 28°C for 36 h. A suspension of Block 22 
was made in STW and adjusted spectrophotometrically to OD600 =0.5 (~ 5 x 10
8 CFU/ml). 
The suspension was serially diluted and plated on Nutrient Agar plates and incubated at 
28°C for 48 h to confirm actual CFU/ml.  In the first set of experiments, Xac suspension 
was diluted in STW to 5 x 106 CFU/ml and phages cocktail to 108 PFU/ml (MOI=20) for 
application; for the second set of experiments, Xac was applied at 5 x 108 CFU/ml and 
phages cocktail at 1010 PFU/ml (MOI=20). Silwett-L77 (silicone-polyether copolymer, 
Fisher Scientific), a wetting agent for increasing inoculum penetration, was used in each 
treatment at a 0.025% (vol/vol) final concentration. After inoculation, the plants were 
covered with white plastic bags for 24 h and then kept in the greenhouse (approximately 
60% relative humidity). All inoculations included a minimum of three leaves at a similar 
developmental stage from each plant, and each treatment comprised five plants. Canker 
symptom progression was monitored phenotypically and the Xac population on inoculated 
leaves was estimated. In brief, three leaf discs randomly selected from each of two 
inoculated leaves were collected with a cork borer (0.8 cm in diameter) and ground in 1 ml 




containing the appropriate antibiotics. After incubation at 28° C for 48 h, bacterial colonies 
were counted and the number of CFU per square centimeter of leaf tissue was calculated. 
The experiments were repeated two times. 
Results and discussion 
 In both sets of experiments, when the phage cocktail was applied either prior to or 
after the inoculation of Xac, the development of canker symptoms on Hamlin sweet orange 
leaves was reduced as compared to the disease control (Xac inoculation alone), as 
evidenced by reduced lesion numbers developed on the leaves surfaces (Figure 13). In the 
first set of experiments, where the phage mixture (108 PFU/ml) and Xac inoculum (5x 106 
CFU/ml) were applied, the pre-Xac treatment showed better canker control than the post-
Xac treatment with fewer lesion formations on the leaves’ surfaces. The mean reductions in 
lesion formations were 52.7% and 47.4%, respectively (Table 13). In the second set of 
experiments, where the phage mixture (1010 PFU/ml) and Xac inoculum (5x 108 CFU/ml) 
were applied, the pre-Xac treatment and post-Xac treatment exhibited a similar control of 
canker symptoms, with a mean reduction in lesions formation of 42% and 44.9% 




Figure 13. Effect of phage treatments on Xac infection on citrus leaves in greenhouse. Phage treatments reduced canker symptom 
development on Hamlin sweet orange leaves spray-inoculated by Xac (106 CFU/ml, up panel; and108 CFU/ml, down panel). Images 
are representative of five independent replicates at 21 days post inoculation. Xac: Xac mixed with sterile tap water alone (disease 
control); Phage: the phage mixture (108 PFU/ml or 1010 PFU/ml) inoculated alone (phage control); Xac - Phage: Xac inoculated 6 h 
before phage application (post-Xac treatment); Phage - Xac: phage applied 6 h before Xac inoculation (pre-Xac treatment), H2O: 
sterile tap water alone.  
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Table 13. Suppression of bacterial canker formation on Hamlin sweet orange by phage treatment. 
Treatmenta Experiment #1 Experiment #2 Mean 
Reduction Lesions/leafb Reductionc Lesions/leaf Reduction 
Xac (106 CFU/ml )  
(disease control) 
29 + 5 - 26 + 6 - - 
Xac (106 CFU/ml ) –Phage (108 PFU/ml) 
(post-Xac treatment) 
16 + 4 44.8% 13 + 3 50% 47.4% 
Phage (108 PFU/ml) –Xac (106 CFU/ml ) 
(pre-Xac treatment) 
14 + 4 51.7% 12 + 4 53.8% 52.7% 
Xac (108 CFU/ml ) 
(disease control) 
75 + 12 - 84 + 15 - - 
Xac (108 CFU/ml ) –Phage (1010 PFU/ml) 
(post-Xac treatment) 
42 + 7 44% 45 + 8 45.8% 44.9% 
Phage (1010 PFU/ml) –Xac (108 CFU/ml ) 
(pre-Xac treatment) 
44 + 9 41.3% 48 + 8 42.8% 42.0% 
a Treatments were applied to Hamlin sweet orange plants. Xac - phage: phage treated 6 h –post Xac inoculation (post-Xac treatment); Phage - Xac: 
phage applied 6 h –prior to Xac inoculation (pre-Xac treatment). 
b Lesion number assessed 21 days after inoculation with the pathogen. An average lesion number of five leaves was recorded. 





 We also monitored the effect of phage treatments on the growth of Xac populations 
in host plants. In the first set of experiments (5x 106 CFU/ml Xac inoculum), the 
populations of Xac recovered from pre-phage treatment and post-Xac treatment were 
approximately 10-fold and 5-fold fewer in CFU per square centimeter of leaf tissues than 
the disease control from 14 to 21 days post inoculation, respectively (Figure 14a). In the 
second set of experiments (5x 108 CFU/ml Xac inoculum), the populations of Xac 
recovered from both pre-Xac and post-Xac treatments were approximately 7-fold less in  
CFU per square centimeter of leaf tissues than the disease control at 21 days post 
inoculation (Figure 14b). There was an observed reduction in bacterial population from 
day 0 to 3 in phage treated (pre-Xac or post –Xac) plant tissue inoculated with 106 or 108 
CFU/ml as compared with the Xac inoculated untreated plants. This drop in the initial 
population is also reflected in the lower number of lesions of leaves in treated plants (Table 
13). The observed increase at both levels of inoculation after 3 days is likely due to the Xac 
population that entered the mesophyll through the stomata that were not exposed to the 
phage treatment. However, Xac population in pre or post – treatment plant tissue did not 








Figure 14. Phage treatments affected the growth of Xac populations on Hamlin sweet 
orange leaves following spray inoculation: (a) 106 CFU/ml, (b) 108 CFU/ml. Phage 
cocktail treatments were applied at and MOI of 20 for plant inoculated at both inoculum 
concentrations.  Bacterial cells were recovered from the leaves at different time points after 
inoculation and quantified using the standard serial diluting-plating method. The values 
shown are means of six repeats and standard deviations. All the assays were repeated two 
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The results of the growth of Xac populations in host plants in Figure 14 correlated 
with the results of lesion formation on the leaves surfaces showed in Table 13. Using 
JMP® Pro v14 (SAS Inst. Inc., Cary, NC, USA), the output of means comparisons for all 
pairs using Tukey-Kramer HSD (p < 0.05) showed that both phage treatments exhibited a 
statistically significant reduction of lesion formation compared to Xac inoculation alone; 
but there was not a statistical difference between the pre-Xac or post-Xac treatments (Table 
14). With one treatment in a 21-day period, we confirmed the efficacy of the phage 
cocktail in reducing canker symptoms in greenhouse trials. 
 
 
Table 14. Effect of phages cocktail treatments on canker symptoms development incited 
by Block22 in greenhouse trials.  
Replicate  Means of lesions formationa 









106 CFU/ml 29a 16b 14b 0.0110 
108 CFU/ml 75a 42b 44b 0.0093 
Experiment #2 
106 CFU/ml 26a 13b 45b 0.0156 
108 CFU/ml 84a 12b 48b 0.0080 
a Means within the same row followed by the same letter are not significantly different according to  the 
Tukey-Kramer HSD multiple comparisons test in JMP® Pro v14, at p = 0.05 level. 
b p = Probability that there are no differences in treatment means according to analysis of variance. 
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CHAPTER V  
CONCLUSIONS AND FUTURE DIRECTIONS 
  
The genus Xanthomonas is comprised of 27 species that can cause serious diseases 
in ~400 plant hosts, including a wide variety of economically important crops, such as rice, 
citrus, banana, cabbage, tomato, pepper and bean (Ryan et al., 2011). The goal of my study 
was to isolate virulent bacteriophages that could be used as biocontrol agents for the 
treatment of citrus canker caused by Xac as an alternative to copper sprays that have a 
negative impact on the plant health and the environment.  
 In this study, I isolated and purified 39 phages from environmental samples that 
formed plaques on Xac strains tested (Chapter II). In depth genomic characterization was 
conducted of three morphologically distinct Xac phages that exhibited different host 
ranges. Phage CCP504, a podophage, was determined to be phiKMV-like, since it contains 
a single subunit RNAP at the end of class II gene cluster of DNA metabolism and the 
metabolism genes follow the order of phiKMV-like phages and therefore a virulent, since 
all known KMV-like phages are virulent.  Annotation of the siphophage CCP513 genome 
revealed that belonged to a novel phage type, whereas phage CCP509 was T4-like and 
virulent. All three phages were determined to utilize type IV pili as their primary receptor 
for infection process. Additionally, genomic analysis of spontaneous phage resistant Xac 
isolates determine that a mutation in pilT, pilR or pilB resulted in phage resistance due to 
abolishment or loss of function of the T4P. In in vitro studies, it was observed that phage 
resistant mutants exhibited reduced growth as compared to the wild type strain, indicating 




 Greenhouse studies were conducted to determine the efficacy of both prophylactic 
and therapeutic treatment with a phage cocktail composed of three KMV-like podophages 
(CCP504, CCP505 and CCP511) and one siphophage (CCP513). A significant reduction in 
lesion formation on leaves of Hamlin sweet orange plants was observed for both pre- and 
post-treated plants, as compared to non-treated. The growth of Xac population in host 
plants was also monitored to determine the effect of phage treatments. There was an 
observed reduction in bacterial population from day 0 to 3 in phage treated (pre-Xac or 
post-Xac) in plant tissue inoculated with at 106 or 108 CFU/ml as compared with the Xac 
inoculated untreated plants.  Additionally, it was observed that the Xac population in pre or 
post-treatment plant tissue did not reach the same level as untreated over a 21-day period 
(Chapter IV). 
 Future studies should focus on the isolation of phages that are non-T4P dependent 
to expand the diversity of adsorption sites in the phage bank for future phage cocktail 
formulation. Additionally, greenhouse as well as field trials should be conducted to 
determine the optimal phage concentration and frequency of phage application to obtain 
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